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Abstract 
This study was designed to test the trypanocidal efficacy of three medicinal 
plants (Erythrina abyssinica, Tinospora bakis and Polygala erioptera) 
against Trypanosoma evansi in experimentally infected rats. Two hundred 
and ninety outbred albino rats were used. The animals were divided into 
twenty nine groups; each group consisted of ten rats. 
All rats were inoculated with parasites mounting to 3 – 4 parasites per field 
intraperitoneally except the negative control group. The plants extracts 
(water, methanolic and chloroformic) were injected intraperitoneally for 
treated groups after appearance of parasitaemia.  
All infected untreated rats died by the end of the second week after 
infection, with decrease in RBCs counts, Hb concentration, PCV, and 
increase in Bil, ALT and AST activity.   
In rats treated with water extract of Erythrina abyssinica the parasitaemia 
disappeared for short period and reappeared again. Rats receiving 100 mg 
and 50 mg of either methanolic or chloroformic total extracts were cured of 
infection but the doses appeared to be toxic. The 10 mg total extract dose 
was more effective in clearing infection.     
In rats treated with water extract of Tinospora bakis parasitaemia 
disappeared temporarily and relapse occurred. The 100 mg dose of the 
methanolic extract cured the infection but was toxic. The 10 mg dose could 
clear the infection without relapse. No antitrypanosomal effect was observed 
with chloroformic extract of Tinospora bakis.        
Polygala erioptera extracts gave the best results. The 100 mg of water 
extract was successful in eliminating infection, but the 50 mg and 10 mg 
water extract could not eliminate the parasite. The 100 mg and 50 mg of 
either methanolic or chloroformic extracts cleared the parasite but were 
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toxic. The 10 mg of either extracts eliminated the infection and all animals 
survived throughout the experiment period. 
In all treated groups there was variable decrease in haematological 
parameters and increase in serum enzymes. 
Further studies are recommended using Polygala erioptera extracts as 
antitrypanosomal treatment.    
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  ﻤﻠﺨﺹ ﺍﻷﻁﺭﻭﺤﻪ
ﺗﻴﻨﻮﺳﺒﻮرا ، إرﻳﺜﺮﻳﻨﺎ اﺑﺴﻴﻨﻴﻜﺎ)ﺻﻤﻤﺖ هﺬﻩ اﻟﺪراﺳﻪ ﻹﺧﺘﺒﺎر ﻓﻌﺎﻟﻴﺔ ﺛﻼث ﻣﻦ اﻟﻨﺒﺎﺗﺎت اﻟﻄﺒﻴﻪ اﻟﺴﻮداﻧﻴﻪ 
  .ﺿﺪ اﻟﻤﺜﻘﺒﻴﻪ إﻳﻔﺎﻧﺰاى اﻟﻤﺤﻘﻮﻧﻪ ﺗﺠﺮﻳﺒﻴًﺎ ﻓﻰ اﻟﻘﻮارض( وﺑﻮﻟﻴﻘﺎﻻ إرﻳﻮﺑﺘﺮا
ﻀﻢ  ﻤﻮﻋﻪ ﺗ ﻗﺴﻤﺖ ﻋﻠﻰ ﺗﺴﻌﺔ و ﻋﺸﺮﻳﻦ ﻣﺠﻤﻮﻋﻪ آﻞ ﻣﺠﻴًﺎ ﻣﻌﻤﻠﺗﻢ إﺳﺘﺨﺪام ﻣﺌﺘﺎن و ﺗﺴﻌﻮن ﻓﺄرًا -
 ﻣﻦ اﻟﻄﻔﻴﻞ ﻋﺪا 501 X5 ﺟﻤﻴﻊ اﻟﻤﺠﻤﻮﻋﺎت ﺗﻢ ﺣﻘﻨﻬﺎ ﻓﻰ اﻟﺼﻔﺎق اﻟﺒﻴﺮﻳﺘﻮﻧﻰ ﺑﺠﺮﻋﺔ ،ﻋﺸﺮة ﻓﺌﺮان
  .        اﻟﺴﻠﺒﻰﺘﺤﻜﻢﻣﺠﻤﻮﻋﺔ اﻟ
ﺗﻢ ﺣﻘﻨﻬﺎ ﻓﻰ اﻟﺼﻔﺎق اﻟﺒﻴﺮﻳﺘﻮﻧﻰ ﻟﻠﺤﻴﻮاﻧﺎت ( ﻣﻴﺜﺎﻧﻮﻟﻰ و آﻠﻮروﻓﻮرﻣﻰ، ﻣﺎﺋﻰ) ﻣﺴﺘﺨﻠﺼﺎت اﻟﻨﺒﺎﺗﺎت -
  .اﻟﻤﺼﺎﺑﻪ ﺑﻌﺪ ﻇﻬﻮر اﻟﻄﻔﻴﻞ
ﻧﻔﻘﺖ ﺑﻨﻬﺎﻳﺔ اﻻﺳﺒﻮع اﻟﺜﺎﻧﻰ ﻣﻦ (  إﻳﺠﺎﺑﻰﺗﺤﻜﻢ)ﺤﻘﻮﻧﻪ ﺑﺎﻟﻄﻔﻴﻞ و ﻏﻴﺮ ﻣﻌﺎﻟﺠﻪ ﻤﻟ ﺟﻤﻴﻊ اﻟﺤﻴﻮاﻧﺎت ا-
ﺗﺮآﻴﺰ اﻟﻬﻴﻤﻮﻗﻠﻮﺑﻴﻦ و ﻣﻜﺪاس اﻟﺪم ﺑﻴﻨﻤﺎ إرﺗﻔﻊ ، اﻟﺤﻘﻦ و إﻧﺨﻔﺾ ﻓﻴﻬﺎ ﻋﺪد آﺮﻳﺎت اﻟﺪم اﻟﺤﻤﺮاء
  .(TSAو  TLA )اﻟﺒﻴﻠﻴﺮوﺑﻴﻦ و إﻧﺰﻳﻤﻰ ﻧﻘﻞ ﻣﺤﻤﻮﻋﺔ اﻷﻣﻴﻦ
ت اﻹرﻳﺜﺮﻳﻨﺎ اﺑﺴﻴﻨﻴﻜﺎ أﺧﺘﻔﻰ اﻟﻄﻔﻴﻞ ﻟﻔﺘﺮﻩ ﻗﺼﻴﺮﻩ ﺛﻢ  ﻓﻰ اﻟﻔﺌﺮان اﻟﻤﻌﺎﻟﺠﻪ ﺑﺎﻟﻤﺴﺘﺨﻠﺺ اﻟﻤﺎﺋﻰ ﻟﻨﺒﺎ-
 ﻣﻦ اﻟﻤﺴﺘﺨﻠﺺ اﻟﻤﻴﺜﺎﻧﻮﻟﻰ أو ﻠﻠﻴﺠﺮامﻣ 05 أو ﻣﻠﺠﺮام001اﻟﻔﺌﺮان اﻟﻤﺤﻘﻮﻧﻪ ﺑﺠﺮﻋﺔ . ﻇﻬﺮ ﻣﺮة اﺧﺮى
ﺜﺮ آ آﺎﻧﺖ اﻻﻣﻠﻠﻴﺠﺮام01ﺟﺮﻋﺔ . اﻟﻜﻠﻮروﻓﻮرﻣﻰ ﺷﻔﻴﺖ ﻣﻦ اﻹﺻﺎﺑﻪ ﻟﻜﻦ هﺬﻩ اﻟﺠﺮﻋﺎت آﺎﻧﺖ ﺳﺎﻣﻪ
  .ﻓﻌﺎﻟﻴﻪ ﻓﻰ إزاﻟﺔ اﻹﺻﺎﺑﻪ
ﺮان اﻟﻤﻌﺎﻟﺠﻪ ﺑﺎﻟﻤﺴﺘﺨﻠﺺ اﻟﻤﺎﺋﻰ ﻟﻨﺒﺎت اﻟﺘﻴﻨﻮﺳﺒﻮرا ﺑﺎآﺲ إﺧﺘﻔﻰ اﻟﻄﻔﻴﻞ ﻣﺆﻗﺘًﺎ ﺛﻢ ﻇﻬﺮ ﻣﺮة  ﻓﻰ اﻟﻔﺌ-
ﺟﺮﻋﺔ .  اﻹﺻﺎﺑﻪ ﻟﻜﻨﻬﺎ آﺎﻧﺖ ﺳﺎﻣﻪﺖ ﻣﻦ اﻟﻤﺴﺘﺨﻠﺺ اﻟﻤﺜﺎﻧﻮﻟﻰ أزاﻟﻠﻴﺠﺮامﻣﻠ001ﺟﺮﻋﺔ . أﺧﺮى
اﻟﻤﺴﺘﺨﻠﺺ اﻟﻜﻠﻮروﻓﻮرﻣﻰ ﻟﻢ ﻳﻈﻬﺮ ﻓﻌﺎﻟﻴﻪ ﺿﺪ .  اﻹﺻﺎﺑﻪ و ﻟﻢ ﺗﻈﻬﺮ إﻧﺘﻜﺎﺳﻪﺖ ازاﻟﻠﻴﺠﺮامﻣﻠ01
  .اﻟﻄﻔﻴﻞ
 ﻣﻦ اﻟﻤﺴﺘﺨﻠﺺ ﻠﻴﺠﺮامﻣﻠ001 ﺟﺮﻋﺔ  . ﻣﺴﺘﺨﻠﺺ ﻧﺒﺎت اﻟﺒﻮﻟﻴﻘﺎﻻ إرﻳﻮﺑﺘﺮا أﻋﻄﻰ أﻓﻀﻞ اﻟﻨﺘﺎﺋﺞ-
ﺟﺮﻋﺔ   .ﻠﻴﺠﺮامﻣﻠ 01 و ﻠﻴﺠﺮامﻣﻠ 05اﻟﻤﺎﺋﻰ ﻧﺠﺤﺖ ﻓﻰ إزاﻟﺔ اﻟﻄﻔﻴﻞ ﺑﻴﻨﻤﺎ ﻓﺸﻠﺖ آﻞ ﻣﻦ ﺟﺮﻋﺘﻰ 
 ﺖ اﻟﻄﻔﻴﻞ ﻟﻜﻨﻬﺎ آﺎﻧﺖﻤﻴﺜﺎﻧﻮﻟﻰ أو اﻟﻜﻠﻮروﻓﻮرﻣﻰ ازاﻟ ﻣﻠﻠﻴﺠﺮام ﻣﻦ اﻟﻤﺴﺘﺨﻠﺺ اﻟ05 ﻣﻠﻠﻴﺠﺮام و 001
 ازاﻟﺔ اﻟﻄﻔﻴﻞ و  آﺎﻧﺖ ﻓﺎﻋﻠﻪﻤﻴﺜﺎﻧﻮﻟﻰ أو اﻟﻜﻠﻮروﻓﻮرﻣﻰ ﻣﻠﻠﻴﺠﺮام ﻣﻦ اﻟﻤﺴﺘﺨﻠﺺ اﻟ01ﺟﺮﻋﺔ . ﺳﺎﻣﻪ
  .ﺔ اﻟﺘﺠﺮﺑﻪﻳﻋﺎﺷﺖ اﻟﺤﻴﻮاﻧﺎت ﺣﺘﻰ ﻧﻬﺎ
 ﺑﻤﻌﺪﻻت  ﻓﻰ ﺟﻤﻴﻊ اﻟﻤﺠﻤﻮﻋﺎت اﻟﻤﻌﺎﻟﺠﻪ إﻧﺨﻔﻀﺖ اﻟﻤﻌﺪﻻت اﻟﺪﻣﻮﻳﻪ و إزدادت إﻧﺰﻳﻤﺎت اﻟﺴﻴﺮم-
  ﻣﺘﻔﺎوﺗﻪ
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ت ﻋﻠﻰ ﻣﺴﺘﺨﻠﺼﺎت ﻧﺒﺎت اﻟﺒﻮﻟﻴﻘﺎﻻ إرﻳﻮﺑﺘﺮا آﻌﻼج ﻣﻀﺎد ﺟﺮاء اﻟﻤﺰﻳﺪ ﻣﻦ اﻟﺪراﺳﺎﻹ ﻣﺸﺠﻌﻪ اﻟﻨﺘﺎﺋﺞ-
  .   ﻟﻠﻤﺜﻘﺒﻴﺎت
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INTRODUCTION 
Camel is one of the most friendly multipurpose domesticated animal. The 
holly Quran stipulated some of its useful properties (And the cattle hath He 
created, whence ye have warm clothing and uses, and whereof ye eat; (5) 
And wherein is beauty for you, when ye bring them home, and when ye take 
them out to pasture. (6) And they bear your loads for you unto a land ye 
could not reach save with great trouble to yourselves. Lo! your Lord is Full 
of Pity, Merciful. (7) (Sura No 16, verses 5-7 Elnahl). In Sudan people 
depend on animals as a first source of food and hard currency source. 
Diseases influence feed intake, growth rate and body gain, reproduction, 
production and feed conversion efficiency.  
The population of the livestock in the Sudan is estimated to be 128.523.000 
animals (3.342.000 head of camels, 41.485.000 head of goats, 48.136.000 
head of sheep, 39.479.000 head of cattle and 370.056.000 head of poultry). 
(MARF, 2002). The greater number is found in Blue Nile state (11.642.942 
head of animals), then Western Darfur state (10.753.521 head of animals) 
and Southern Darfur state (10.155.074 head of animals) (MARF, 2001). 
 The Camel (Camelus dormedarius) plays an important role in arid and 
semi-arid zones where it is used by pastoral communities as a source of 
meat, milk and drought, transport and most importantly as a sign of wealth 
and prestage. Its population densities are highest in the arid zone of Africa, 
particularly in the arid low land North Eastern Africa, i.e. Somalia, Sudan, 
Ethiopia, Kenya and Djiboti. (Shwartz & Dioli, 1992).  
Sudanese camels are affected by one of the most serious protozoan disease 
called trypanosomosis (Wilson, 1984).      
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Animal trypanosomosis is a group of diseases caused by flagellated 
protozoan of the genus Trypanosoma, which belong to family 
Trypanosomatidae and order kinetoplastida. The vector encompasses about 
> 10 million square kilometers in the most fertile land of Africa (Atang, 
1982) and is widespread in East Africa (Ethiopia, Sudan, Somalia, and 
Kenya) and West Africa (Chad, Mali, Mauritania, and Niger). It has also 
been described in the Middle East, and the far East (Wilson, 1984). In Africa 
most of the trypanosome species that are pathogenic to man and animal are 
transmitted cyclically by tsetse flies and/or mechanically by other 
haematophagus insects mainly Tabanidae. Other transmitters incriminated 
include Muscidae and Stomoxidae (Ford, 1971). Control of the disease in 
Sudan by vector control is not established as the biology of the incriminated 
blood sucking flies is not well studied. Also seasonality of their abundance 
and patch distribution make it difficult to adopt efficient programs for their 
control. Chemotherapy is the most commonly recommended method of 
control. Literature reveals that limited success had been achieved in the field 
of chemotherapy and allied disciplines to discover or develop ′ideal′ 
trypanocides (Jennines et al., 1993). A number of drugs have been tried 
against trypanosomosis caused by T.evansi. However, the extensive and long 
term use of the small number of commercially available trypanocides 
resulted in the appearance of drug resistance (Pham, 1985). Control of 
animal trypanosomosis is important but difficult because of the wide range 
of animal species that are susceptible to the disease and the diversity of 
Trypanosoma species. Control may involve initiation and maintenance of 
tsetse control programs and/or chemotherapy and chemoprophylaxis for 
livestock (Ikede, 1989; Williamson, 1979). Total expenditure on 
trypanocides in sub-Saharan Africa has been estimated at between USD 12 
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and 35 million per year, or between 30 – 87 million doses (Sones, 1999; 
Kristjanson et al., 1999). Chemotherapy in livestock currently depends on 
the salt of mant compounds, several of which are chemically closely related. 
These groups are the phenanthridines, arsenical compounds, the aromatic 
diamidine, quinapyramine and suramin. After the introduction of 
isometamidium in 1961 (Berg et al., 1961) the development of new 
trypanocidal drugs has made little progress. Resistance to these drugs is 
apparently on the increase (Peregrine, 1994) and the main means of 
controlling the disease is therefore under threat. 
Drug resistance in trypanosomosis can be defined as "the ability of a 
trypanosome strain, formerly exposed to a drug, to survive, despite the 
administration and absorption of a drug given in doses equal to, or higher 
than the recommended (Schillinger, 1985). Drug resistance is an absolute 
state but is correlated to a particular dosage. Between complete sensitivity 
and complete response of trypanosomes to trypanocides, ranging from a loss 
of effect, demonstrable only by occasional re-appearance of the parasite in 
the blood, to a level of resistance at which the drug apparently has no effect 
(Schillinger, 1985). There is increasing evidence of chemo-resistance in 
cattle (Bauer et al., 1999). Lack of much interest by the pharmaceutical 
industry to venture into development of new antitrypoanosomal drugs has 
been a major stimulus to an intensification of research into the few existing 
drugs (Kinabo, 1993). The research for new approaches to control African 
trypanosomosis will require intensive and extensive research into several 
aspects of the basic biology of the parasites themselves, the role of the tsetse 
flies in transmitting the infection and the response to infection of different 
livestock species and breeds (Nantulya & Moloo, 1988). 
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Objectives: 
This is a trial to focus on the medicinal plants, a trial to find new 
trypanocidal treatment with minimal or no resistant or toxic effects. Thus the 
main objectives of this search for phytotrypanocidals are: 
1. To study the efficacy of plants (Erythrina abyssinica, Tinospora 
bakis and Polygala erioptera) water, methanolic and chloroformic 
extracts. 
2. To study the pharmacotoxicity of these plants in rats. 
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CHAPTER ONE 
LITERATURE REVIEW 
Trypanosomosis is a disease caused by haemoflagellate protozoa classified 
as Trypanosoma spp. It is a disease of man causing sleeping sickness as well 
as a disease of animals causing animal trypanosomosis (Clarkson, 1968). 
Trypanosomes are frequently found in the blood of various animal species in 
many regions of the world. Trypanosomes are able to infect a wide variety 
of domestic animals and more than 30 species in the wild (OIE, 2005).  
The majority are not pathogenic, but some species are of considerable 
economic importance causing disease in man and animals (Clarkson, 1968). 
African animal trypanosomosis (AAT) is considered a major constraint to 
livestock productivity in sub-saharan Africa (SSA) (Leak, 1988) and have 
profound effects on rural development over vast areas (Holmes, 1997). The 
disease is generally a chronic condition, which is usually fatal if not 
appropriately treated. It leads to a considerable loss of weight and anemia, 
and may be associated with oedema, dermatitis and nervous disorders 
(Finelle, 1983). In Africa, various haematophagus insects, mainly Glossina 
species commonly known as tsetse flies, cycilically transmit the 
trypanosoma species. These are considered to be the true vector of these 
parasites. Tsetse flies occur in Africa over an area of approximately 10 
million Km² extending in both sides of the Equator. The Northern limit of its 
range lies approximately along latitude  10 °N while the Southern limit 
correspond roughly to latitude 20 °S, but curves down to the southern cost of 
Africa to 30 °S. The ecoclimate generally corresponds to more than 1000mm 
of rainfall (Itard, 1981). 
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1.1 Classification of Trypanosoma evavsi 
African trypanosomosis are a group of allied protozoan diseases in animals 
and man causes by species of the genus Trypanosoma. Trypanosomes are 
members of the order Kinetoplastida, family Trypanosomatidae, and genus 
Trypanosoma (Ford, 1971).  
Phylum: Protozoa 
Subphylum: Sarcomastigophora 
Super class: Mastigophora 
Class:  Zoomasigophorea 
Order: Kinetoplastida 
Suborder: Trypanosomatida 
Family: Trypanosomatidae 
Genus:  Trypanosoma 
Subgenus:  Pycnomonas Nannomonas  Duttonella  Trypanozoon  
Species: suis congolense simiae vivax  brucei 
Subspecies:     vivax   uniforme   viennei      
                   brucei  rhodesiense  gambesiense  equiperdum  equinum   evansi 
(Soulsby, 1982) 
Mammalian trypanosomes can be divided into two major groups; the 
Stercoraria and Salivaria on the basis of their invertebrate cycle (Hoare, 
1964). The Stercoraria contain species in which the entire development is 
confined to the gut of the vector and infective metatrypanosomes can be 
found in the faeces of the insect and infection occurred through 
contamination of woonds and mucus membane. The two most well known 
species of Stercoraria are T.cruzi, the pathogenic trypanosome causing 
Chagas disease in Latin America, and T.theileri, which is usually non 
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pathogenic (Stephen, 1986). Salivarian trypanosomes complete their cyclical 
development in the 'anterior station' of the vector and infective stages are 
transmitted to the mammalian host through the bite of an infected fly. 
T.evansi and most of the pathogenic African trypanosomes are classified as 
salivarian trypanosomes, though T.evansi has no cyclical development in the 
insect vector. Like T.brucei and T.equiperdum, T.evansi is classified in the 
sub-genus Trypanozoon. Other important sub-genera of veterinary 
importance in the salivarian group are Nannomonas, with T.congolense and 
T.simiae, and Duttonella, with T.vivax. 
 
1.2 Transmission of trypanosomosis 
1.2.1 Routes of transmission 
African trypanosomosis are transmitted by a number of species of the genus 
Glossina (Thomas & Jeremy, 1981). Tsetse flies (Glossina spp.) are found 
only in Africa. They are the biological and/or mechanical vector of 
trypanosomes and constitute a potent and constant threat to humans and 
livestock over much of sub-Saharan Africa (Gooding & Krafsur, 2004). 
Nieschulz, (1930) in a number of experimental studies, demonstrated that 
over 25 Tabanus species can transmit the disease. Not only the structure of 
its mouthparts but more importantly the feeding behaviour of the fly made it 
an efficient vector (Luckins, 1988). Tabanus species may consume volumes 
blood up to 200 µl (Hoare, 1972), and are determined feeders, quickly 
changing hosts. Although Chrysops, Haematopota and Stomoxys have been 
described in a number of Asian countries including Indonesia and Vietnam 
(Dieleman, 1986; Lan, 1996), their role in the transmission is considered of 
less importance (Foil, 1989). 
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In Africa, the tsetse fly, like other blood-sucking flies, can act as mechanical 
vectors in the areas where both T.evansi and these flies occur (Hoare, 1972).          
There are three major types of transmission of trypanosomes: 
1. cyclical transmission 
2. mechanical transmission 
3. others 
Transmission by insects may be cyclical by Glossina species, or mechanical 
by other biting flies. A part from transmitting trypanosomes cyclically, 
Glossina spp can also act as a mechanical vector (Uilenberg, 1998). 
1.2.1.1Cyclical transmission 
During cyclical transmission, tsetse flies acquire infection of bloodstream 
trypomastigotes from the mammalian host blood (Radostits et al., 2000). 
The trypanosomes enter the midgut where they transform through 
longitudinal binary fission into epimastigotes in the cardia in T.cruzi. Later 
they penetrate the haemocel via the peritrophic membrane and the midgut 
epithelium into the salivary glands or proboscis of the fly where they 
develop into metacyclics, which are infective. During feeding, these 
infectious stages are inoculated into the sub cutaneus tissues of the host 
(Aksoy et al., 2001). 
1.2.1.2 Mechanical transmission 
Mechanical transmission is materialized by two means: 
A/ by biting insects: 
In Africa, both T.vivax and T.b.brucei have spread beyond the "tsetse fly 
belts" (Roder et al., 1984), where transmission is principally by tabanid and 
hippoboscid flies. Of the three African animal trypanosomes, only T.vivax 
occurs in the Western Hemisphere in at least 10 countries in the Caribbean 
and South and Central America (Hoare, 1972). 
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B/ By iatrogenic means: 
These are caused by the careless operators using unhygienic procedures, 
such as contaminated instruments. This can occur when using the same 
needle or surgical instrument for more than one animal, at sufficiently short 
intervals that the blood on the needle or instrument does not dry. It is not an 
uncommon occurrence when animals are vaccinated or treated by injection, 
or when blood is colleted from several animals in a row without changing or 
disinfecting the needles. It may occur when several animals are subjected at 
short intervals to a surgical intervention (dehorning, castration…etc) without 
properly disinfecting the instruments (Uilenberg, 1998). 
1.2.1.3 Transmission by other means: 
A/ Carnivores were reported to be infected with T .evansi and T .brucei by 
ingesting meat or organs from infected animals, as long as these are still 
sufficiently fresh to contain live trypanosomes (Uilenberg, 1998). It is 
postulated that trypanosomes can penetrate through the mucosa. 
B/ In Latin America, transmission is not only through insects but the 
vampire bat (Desmodus rotundus) also plays an important role (Stephen, 
1986). These bats are ideal vectors, when feeding on hosts such as cattle 
with very scanty parasitaemia; their infection is ensured by the large amount 
of blood that they consume (50 ml), while the subsequent proliferation of the 
trypanosomes in their own blood increases the chances of successful 
transmission to new hosts. The role of bats is thus twofold that of host and 
vector (Hoare, 1965). 
C/ All trypanosome speices are occasionally transmitted congenitally from 
the mother to the offspring, either through the placenta while the fetus is still 
in the uterus, or when bleeding occurs during birth. Congenital transmission 
of T.vivax for example had been observed in Latin America as well as in 
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Africa, but its real importance is not well known (Uilenberg, 1998). Pathak 
and Kapoor, (1999) detected T. evansi in blood samples from an aborted 
donkey fetus. 
D/ Venereal transmission is the normal means by which dourine of equine, 
caused by T.equiperdum, is propagated (Uilenberg, 1998). 
 
1.3 The Vector 
Tsetse flies are classified generally in three main groups: 
Morsitans grgoup: G.swynertoni, G.pallidipes and G.morsitans 
subsmorsirans, which favor the woodlands of Savannah. 
Palpalis group: G.fuscipes, G.tachinoides and G.palpalis gambiense, which 
prefers the shaded habitat immediately adjacent to rivers and lakes 
Fusca group: G. brevipalis and G.longipennis, which favor the high dense 
forest areas (Leak, 1998). 
The morsitans group is of great importance in the transmission of animal 
trypanosomosis and the palpalis in the transmission of human sleeping 
sickness (Rogers, 1991). 
African animal trypanosomosis (AAT) is considered a major constraint to 
livestock productivity in sub-Saharan Africa (SSA) (Leak et al., 1988) and 
has profound effects on rural development over vast areas (Holmes, 1997). It 
is estimated that tsetse flies are distributed over approximately 11 million 
km2 of Africa (Jordan, 1986), which is about 37% of the continent 
(FAO/WHO/OIE, 1982). 
In Africa, beyond the northernmost limits of the tsetse fly belt, and in parts 
of East Africa, camels are the most important hosts (Dia et al., 1997), whilst 
in Central and South America the horse is principally affected (Monzon et 
al., 1990; Silva et al., 1995).  In Asia, a much wider range of hosts is 
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involved, including the Bactrian camel and dromedaries, buffalo, horses and 
pigs (Pathak et al., 1993; Partoutomo et al., 1994; Tuntasuvan et al., 1996; 
EL-sawalhy & Seed, 1999; AL-Rawashdeh et al., 2000; Pacholek et al., 
2001).  This is contrary to observations in Africa, South America, where 
there is little evidence to suggest that domesticated livestock other than 
camels and horses, are clinically affected with Trypanosoma evansi. 
Nevertheless, there are reports of serological evidence of infection in goats 
and sheep from the Sudan and in cattle from Brazil (Boid et al., 1981; 
Franke et al., 1994; Luckins, 1998) and both goats and cattle have been 
considered as potential reservoirs of infection (Dennings et al., 1989; 
Luckins, 1998).  
  
1.4 Trypanosomosis in Sudan 
In Sudan, trypanosomosis has been recognized as an important disease of 
livestock since 1904 when it was recorded that 87 cattle were sick of 
trypanosomosis when they came to Khartoum from Upper Nile province 
(Annual Veterinary Department). In 1908 Dr. Wenyon reported the disease 
in camels in Bahr Elgazal province (Elkarib, 1961). In the study of Kheir et 
al., 1992 along Sudan Ethiopian border in an area extending from Khor 
Yabous (lat.9o 45 long 43o 10 ) in the South to River Setit in the North 
(including areas of Rivers Rahad, Dinder, the Blue Nile and Kurmuk 
district) T.congolense, T.brucei and T.vivax were found. Five T.vivax strains 
isolated from Sennar (Blue Nile State), Gedid (40km from Khartoum state), 
Jabal Awlia (50km from Khartoum State) and from Soba (20km from 
Khartoum State) were found to be infective to white mice (Abdoon et al., 
2001). 
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Bovine trypanosomaisis is mainly a problem of mechanical transmission by 
the genera tabanids, stomoxys and possibly others. The main cattle-rearing 
zone lies north of the tsetse zone, in Bahr Elgazal, Darfur, Kordofan, Upper 
Nile and the Blue Nile province (Elkarib, 1961). T. congolense occurs 
throughout, and in areas just north of the tsetse zone. It may also occur in 
areas farther north. T.vivax occurs in the tsetse zone and extends farther 
north than T.congolense east from parallel 15th north. T.brucei affects cattle 
in the tsetse zone and possibly immediately north of it.  Outside the tsetse 
zone T.congolense is widespread in Bor, Central Nuer Province and Malakal 
district of the Upper Nile province. T. brucei is commonly found in tsetse 
areas and T. vivax outside the tsetse zone. (Elkarib, 1961). 
1.4.1 Trypanosomosis outside the tsetse belt in the Sudan 
Ismail and Shomain (1975) reported the presence of T.vivax in Damazin 
(Blue Nile). Homeida, (1993) recorded T. vivax in Sennar, Kosti and El 
Deuim. Surveys conducted in South Darfour area along Bhar El Arab site, 
the tsetse fringe and in South Kordfan revealed that the prevalent species of 
trypanosomes were T. vivax, T. brucei and T.congolense (Hall et al., 1990) 
T.evansi was recorded in camels comming from El Gadarif State (Eastern 
Sudan) to El-Mwelh market (Khartoum State) (Fairouz, 2000). 
 
1.5 African animal trypanosomosis 
African animal trypanosomosis is a disease complex caused by tsetse-fly-
transmitted Trypanosoma brucei brucei, T.congolense or T.vivax. African 
animal trypanosomosis is most important in cattle but can cause serious 
losses in pigs, camels, goats, and sheep (Mulligan, 1970). Wildlife, i.e. 
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warthog, bush pig, duiker, bush buck, kudu, buffalo and monitor lizard are 
the natural hosts of tsetse and may acquire prolonged, symptomless 
trypanosome infections. Livestock exhibit a range of susceptibilities to 
infection, from refractory to highly vulnerable (Bourn et al., 2001). 
However, the wildlife in Africa generally tolerates infection and often serves 
as a reservoir for human and livestock-infective trypanosomes (Taylor & 
Authie, 2004). Monkeys, rats, mice, guinea pigs and rabbits can also be 
infected by trypanosomes; ruminants, wild equidae, lions, leopards and wild 
pigs can serve as carriers (OIE, 2005). 
1.5.1 Cattle trypanosomosis (Nagana): The most pathogenic species for 
cattle is T.congolense (Shah & Say, 1989). Zebu breed are the most 
susceptible and are not raised in the tsetse fly belts. In Zebu, 2—3 weeks 
after infection, the animal suffer from sever bouts of fever (temperature over 
40C°) with weekness and prostration. Emaciation sets in gradually, leading 
to cachexia. Oedema is rare but severe anaemia may occur. Lymphadenitis 
with hypertrophy of the prescapular and precrural lymph nodes is also 
observed. The hair is ruffed and falls out in patches on the back. Lacrimation 
and conjuctival petechiae, anoxia, motor incoordination and paresis can be 
seen. Exhaustion following prolong decubitus causes death as hypothermia 
set in. Occasionally, the animal recovers after a long convalescence (Shah & 
Say, 1989). In zebu, T.vivax causes acute disease and death compared to 
T.congolense. T.brucei infection is rarely acute and produces no distinct 
symptoms. However, the entire complex of the symptoms can support 
diagnosis of trypanosomosis, particularly in an infested environment. 
Clinical diagnosis must, however, by confirmed by laboratory findings 
(Shah & Say, 1989). 
 33
Horses with fulminating infections are a dangerous source of infection for 
cattle or buffalo (Luckins, 1996). 
1.5.2 Small ruminant trypanosomosis: Although these animals may be 
susceptible to the different trypanosomes. The highly susceptible Sahelian 
breeds avoid the tsetse fly infested areas, while in the Guinean zone, the 
local dwarf breeds seem to be completely resistant. In nature, 
trypanosomosis is a chronic disease in sheep and goats and may last for 
several weeks to several months. Symptoms are mild with attacks of high 
temperature, rough and dull coat, rheumy eyes, cachexia and paresis in the 
terminal phase (Shah & Say, 1989). Sheep and goats are readily infected 
with T.vivax and are excellent laboratory animals for maintaining strains of 
the organism. Most infections are fatal, although a few sheep may develop 
chronic infections and survive for prolonged periods. Massive parasitaemia 
is sometimes observed, especially in goats. Sheep and goats are not often 
found infected with trypanosomes under natural conditions (Mulligan, 
1970). There are reports of natural infection in goats and sheep by T.evansi 
in Sudan (Boid et al., 1981). 
1.5.3 Equine trypanosomosis: equine are susceptible to the infection by 
T.equiperdum, T.brucei, T.congolense, T.evansi, T.uniforme and to some 
extent T.vivax (Mulligan, 1970). Observations on clinical trypanosomosis in 
the horse have indicated that T.vivax infection is a relatively innocuous 
disease in both West and East Africa. Horses, donkeys and mules are very 
susceptible to infection with T.brucei and deaths occur within a forty night 
to three months in untreated animals. There are few reports in the literature 
on the effect of T.congolense in equines (Milligan, 1970). Stephen (1970), 
found that the infection was very mild and although the anaemia was 
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moderately severe, the animal remained alert and live, and by day 45 the 
horse recovered spontaneously. 
Natural infection of horses with T.equiperdum causes a disease known as 
dourine. Transmission occurs from stallion to mare or vice versa by direct 
contact of the mucus membranes of the genitalia during the act of coitus 
(Milligan, 1970). T.brucei is very virulent in equines, chiefly horses, causing 
an acute or per acute infection with hyperthermia; rapid emaciation; 
prostration; bristling coat; oedema of the face and lower parts of the thorax 
and the abdomen; hock and fetlock joint, and genitalia; ocular congestion 
and keratitis; nasal discharge, and occasionally wheals of urticaria on the 
neck, flanks, and back. The most characteristic signs are oedema in the 
lower parts of the body, keratitis, and locomotor ataxia. Death may occur 
from 15days to 3 months after disease onset. 
T.vivax and T. congolense infections are usually chronic with progressive 
anaemia and emaciation, irregular bouts of fever, corneal opacity and nasal 
discharges; oedema is rare. The animal can heal spontaneously. However, 
when animals are overworking or suffering from concision, the disease can 
become acute (Shah & Say, 1989). 
1.5.4 Rodent trypanosomosis: Trypanosome was found in 1/33 domestic 
mice caught in St. Louis, Senegal. Morphologically, it closely resembles the 
trypanosomes of other small mammals-rat, rabbit, and squirrel. The rodent 
trypanosomosis is caused by large group of parasites that are distributed 
wide-world and include more than 40 species of trypanosoma of the 
subgenus Hereptosoma (Hoare, 1972) among which are T.lewisi. T.dultonu 
and T.musculi. 
1.5.5 Camel trypanosomosis: the most pathogenic species to camels is 
T.evansi (Dia et al., 1997). Trypanosoma evansi was the first trypanosome to 
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be described as causative agent of mammalian trypanosomosis. According to 
Mc Fadyean (1894), Stell made similar observation during an outbreak of a 
disease in transport mules in Birma in 1885. The most common species 
known to be affected by T.evansi are primarily equines (horses, donkeys and 
mules) and camels. However, other species, particularly cattle (South and 
Central America) and buffalos (Asia), may be infected, and these can act as 
asymptomatic reservoir. The Vampire bat Desmodus have also been 
identified as host in South America (Uilenberg, 1998). In Africa and Asia; 
sheep, goats, deer and antelope are carriers of T.evansi. Although dogs are 
highly susceptible; the acute course of the disease disqualifies these as 
effective reservoirs. In India there are reports of T.evansi from Tigers, foxes 
and Indian elephants. 
1.5.5.1 Distribution and origin: T.evansi is widely distributed in old world 
tropics and neo-tropics. It is believed to have originated in Africa as a result 
of camels entering the tsetse belt and becoming infected with polymorphic 
T.brucei; returning infected camels then become the source of infection for 
the other camels as the disease was spread mechanically by biting flies. The 
movement of camels across the Sahara spread the disease throughout North 
Africa, and their use in Asia resulted in an eastward spread. It is believed the 
Mauritius outbreaks of T. evansi originated in India. The disease is found as 
far East as Indonesia and the Philippines and throughout the Middle East, the 
Indian subcontinent and into the more temperate parts of Russia. T.evansi 
was also found in North America and Australia but has been eradicated from 
these areas. The organism is likely to have been imported into South 
America with the horses from Spanish conquistadors, or by the importation 
of cattle; neither equines nor bovines were indigenous to the neotropics. It is 
known on how many occasions T.evansi was introduced to the new world.  
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1.5.5.2 Morphology: The trypanosome consists of a single cell varying in 
size from 8 to over 50 µm. There are distinct differences in appearance, 
shape and size between the various species of trypanosomes, allowing 
specific identification (Uilenberg, 1998). The salivaria group of 
trypanosomes may or may not have a free flagellum, the kinetoplast is 
terminal or sub-terminal, and the posterior end of the body is usually blunt. 
They develop as trypomastigotes within the mammalian host and are usually 
pathogenic (Mulligan, 1970). 
T.evansi is typically represented almost exclusively by thin trypomastigotes 
comprising slender and intermediate forms corresponding to those in T. 
brucei. The slender forms have a long free flagellum and a narrow posterior 
extremity, which may be rounded or truncated, with the kinetoplast situated 
at some distance from the tip. The intermediate forms have a shorter free 
flagellum and a short, frequently pointed, posterior extremity, with the 
kinetoplast lying near this end (Hoare, 1972). 
In the blood stream T.evansi usually occurs as monomorphic 
trypomastigotes 15 – 36 µm in length, with a mean of 24 µm. There is small 
sub-terminal kinetoplast in organisms from population who are not 
dyskinetoplastic. The morphology is therefore typically that of slender forms 
of other members of the subgenus trypanozoon. Occasionally stumpy forms 
are observed, but the proportion of such forms is very low; posternulclear 
forms have been observed in some isolates. 
1.5.5.3 Transmission of T.evansi: few reports have been published on 
transmission of T. evansi by flies since those of Cross and Patel (1922) and 
Nieschulz (1930). No cyclical transmission of T.evansi occurs and the 
infection is transmitted between hosts by mechanical transmission effected 
by biting flies (Tabanus) and stable fly (Stomoxys). This method of 
 37
dissemination depends on the movement of a fly with a trypanosome 
contaminated mouth-parts to a new host in a short time, so the parasites in 
the mouth-parts remain infective. Such transmission depends on an 
interrupted feeding, as it is necessary to the fly to continue to probe and feed 
when it has moved to another host. Thus the shorter interval between feeds 
or attempted feeds the greater the chance of transmission. It is established 
that Tabanids are the insects most capable of transmitting T.evansi. Gruvel 
& Balis (1965) stated that the disease in Chad exhibited seasonal incidence 
originating each year from domestic foci. There is an apparent link between 
the seasonal occurrence of outbreaks of T.evansi in camels in Sudan and that 
is become of the greatest abundance of Tabanids during the rainy seasons. 
However, this species is present throughout the year ensuring that 
transmission continues, albeit to a lesser exetent. Most outbreaks occurred 
during the rainy seasons especially at its end. Yagi & Razig (1972) reported 
similar findings in Sudan. There is a definite correlation between the 
seasonal outbreaks of T. evansi infection and the increase of Tabanids during 
the tropical rainy season in the Sudan (June to October) (Mahmoud & Gray, 
1980). Experimental studies have shown that T. evansi dose not survive in 
the gut of the biting flies, even in Glossina, being destroyed within hours of 
ingestion. Stomoxys are less efficient vectors of T.evansi, but may be 
important in stables where horses are confined. Hoare (1967) described the 
transmission of T.evansi and T.equiperdum in horses and cattle in South 
America by the bite of the vampire bat. 
In central and South America vampire bat (Desmodes rotundus) which are 
obligatory blood suckers, become infected via the oral mucous membranes 
when feeding on T.evansi infected cattle. The infection can persist in bats for 
up to one month and may be fatal. However, during this time while biting at 
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night, the bat transmits the infection from the oral secretion to new host. 
Vampire bat imbibe up to 50 ml of blood at a meal and a few parasites are 
usually present. Parasite number increase in the bats, make transmission at 
each subsequent feed more likely. Transmission of T.evansi to carnivores by 
eating infected carcasses has also been demonstrated (as with T.congolense) 
(Uilenberg, 1998). 
                              
1.6 Pathogenesis 
Infected tsetse flies inoculate metacyclic trypanosomes into the skin of 
animals, where the trypanosomes grow for a few days and cause localized 
swelling (chancres). They enter lymph nodes, then the blood stream, where 
they divide rapidly by binary fission. T.brucei and T.vivax invade tissues and 
result in damage to several organs (Blood et al., 1989). 
When the animal is infected with trypanosomes, antibodies against the 
surface coat of the parasite are produced. However, trypanosomes have 
multiple genes, which code for different surface proteins, allowing 
organisms with new surface coat glycoproteins to elude the immune 
response. This process is referred to as 'antigenic variation' and results in the 
persistence of these organisms. Antigenic variation has so far prevented the 
development of a vaccine and permited re-infection when animals are 
exposed to tsetse carrying trypanosomes with surface coat glycoproteins of a 
new antigenic type (Blood et al., 1989). 
The real cause leading to the death of the animal is not fully understood. 
However, it is believed that the parasite releases toxic substance when it is 
destroyed within the circulatory system. In the some cases the sudden 
release of large amounts toxins triggers chain reactions which produce a 
shock-like syndrome (Seifert, 1996). Therefore, the damage to the host does 
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not depend on nutrients being depleted by the parasite but rather on the 
production of toxic substances (Mehlhorn & Piekarski, 1989). 
Oedema is often present in trypanosomosis particularly in horses (T.evansi). 
There is evidence of increased permeability of blood capillaries, and 
therefore leakage of blood plasma leading to swellings (Uilenberg, 1998). 
Anaemia appears with progressing parasitaemia and there is lysis of large 
numbers of red blood cells resulting in a drop in PCV% (Coetzer et al., 
1994; Youssif et al., 2007). Metabolic disorders are observed in the host due 
to a trypanosomes-induced hypothyroid status (Abebe & Eley, 1992) and 
pituitary dysfunction during trypanosomosis (Abebe et al., 1993a; b). The 
ability of trypanosomes to change their surface-coat-antigens continuously 
leads to exhaustion of antibody production by the host leading to 
immunosuppression (Brown et al., 1990; Hörchner, 1993). Acute infections 
associated with high parasitaemia may lead to death of an animal still in 
good body condition. However, chronic trypanosomosis associated with 
progressive emaciation and eventually, cachexia. This is usually 
accompanied by low level of parasitaemia and death in untreated cases 
(Coetzer et al., 1994).                             
Trypanosomosis, like other infectious diseases, starts with an increase of 
body temperature. It is the dominant feature (Jennings et al., 1974; Losos & 
Ikede, 1972; Luckins, 1999), which has two phases: an acute haemolytic 
phase associated with rising parasitaemia and a chronic phase associated 
with declining parasitaemia. Chronically infected animals show 
immunosuppression associated with depletion of lymphoid cells. In acute 
stage of the disease the lymph nodes and spleen are packed with 
proliferating germinal centers and necrotic foci are found in the brain, heart 
and skeletal muscle (Losos & Ikede, 1972). Myocarditis and heart failure is 
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often the direct cause of death. Dargie et al., (1979) stated that the infection 
might be acute causing rapid death due to congestive heart failure or chronic 
causing remittent fever or emaciation. The reproductive system is frequently 
affected and "abortion storm" and infertility are common in herds in areas of 
high trypanosome challenge. (Yagil, 1982).  
1.7 Biochemical changes due to trypanosomosis 
The serum Aspairtate amino transferase (AST) and Alanine amino 
transferase (ALT) activities were increased in infected T. equiperdum 
donkeys (Aliyu et al., 1997), and in infected T.evansi goats (Fairouz, 2000). 
Infection with T.congolense in cattle caused hypothyrodism (Abebe & Eley, 
1992). A similar effect was observed in goats infected with T.vivax (Dam et 
al., 1998a; Fairouz, 2000).  
1.8 Economic implication of African animal trypanosomosis 
Animal trypanosomosis has serious economic consequences; including loss 
of body condition and decreased productivity. In peracute and acute cases it 
has high mortality rates. Decreased milk yield, poor meat quality, and 
infertility are major implications of chronic cases. In addition there is the 
added expenditure on treatment and control programs (Ikede et al., 1988; 
Uilenberg, 1998; Shaw, 2004) Agricultural communities are also denied the 
benefits of draught animals. In addition, concentration of cattle in marginal 
land results in overgrazing and subsequent erosion (Uilenberg, 1998). FAO 
estimates that about three million cattle die each year due to AAT (FAO, 
2000). Other valuable livestock, such as camels, also suffer from 
trypanosomosis (ICIPE, 2006).   A 25% decline in milk yields was reported 
by Agyemang et al., (1991). Other production losses due to trypanosomosis 
include neonatal mortality and poor growth rates. It has been shown that 
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infected bulls were unfit for breeding due to poor semen quality and lack of 
libido (Sekoni et al., 1990).   Thirty five millions doses of trypanocides are 
administered each year to protect livestock in tsetse infected areas (Sones, 
2001). In sub-Saharan Africa for example, in addition to the enormous direct 
losses, more than US$ 20 million are spent per anum on trypanocides, 
accounting for 44% of the total expenditure in veterinary drugs (Solano et 
al., 1999). Annual losses due to trypanosomosis were estimated to be in the 
range of US$ 2.4 million, largely due to mortality in infected animals 
(Solano et al., 1999). Direct losses were estimated by FAO, (2004) to 
amount to between US$ 1-1.2 billion each year whereas the indirect impact 
of AAT on agriculture in sub-Saharan Africa exceeds this amount. A 
pondered evaluation extrapolated for the total tsetse-infested lands values the 
total losses, in terms of agricultural Gross Domestic Product, at US$ 4.75 
billion per year (FAO, 2004). 
Losses in meat production, milk yield, and traction power are estimated to 
cost approximately US$ 500 million annually and, if lost potential in 
livestock and crop production is considered, then trypanosomosis may be 
costing Africa an estimated US$ 4.5 billion per year (Budd, 1999). 
Economics of camel trypanosomosis: 
Throughout Africa, camel trypanosomosis is caused mostly by T.evansi and 
this is the major protozoal disease affecting camels. Immature, stressed, and 
lactating camels are extremely vulnerable (Schwatrz & Dioloi, 1992).  
 
1.9 Diagnosis 
The primary reason for diagnosis of animal trypanosomoses is for the 
appropriate application of therapeutic and prophylactic measures. Other 
reasons for diagnosis include the need to target and monitor tsetse control or 
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eradication operations, investigations into the efficacy of chemotherapy and 
particularly trypanocidal drug resistance, and pathophysiological, 
epidemiological and socio-economic studies. The type of diagnostic test 
used in the detection of infections caused by the animal trypanosomoses will 
vary according to the epidemiological characteristics of the disease and the 
strategy for control. Where tsetse-transmitted trypanosomoses occur and 
where disease prevalence is high, even tests of low diagnostic sensitivity 
will suffice if chemotherapy or chemoprophylaxis is administered on a herd 
basis. However, in many situations where mechanically transmitted 
trypanosomosis is found, drugs are often administered therapeutically to 
individual infected animals and it is essential that more sensitive diagnostic 
tests be used in order to detect active infections. 
Trypanosomosis should be suspected when an animal in an endemic area is 
anaemic and in poor condition. Confirmation depends on the demonstration 
of the organism in blood or lymph node smears. 
 Routine diagnosis of trypanosomosis in the field is undertaken via clinical 
signs and knowledge of the endemicity of the disease in the area (Blood et 
al., 1989; Coetzer et al., 1994). More sensitive diagnostic methods, 
including the detection of trypanosome-specific antibodies and antigens 
have been developed (Luckins & Mehlitz, 1976; Luckins, 1977; Nantulya et 
al., 1992). 
1.9.1 Clinical diagnosis  
Clinical signs of acute bovine trypanosomosis include anaemia, weight loss, 
roughness of the hair coat, enlargement of peripheral lymph nodes, pyrexia, 
abortion, reduced milk yield and, in the absence of treatment, death. 
Hence trypanosomosis should be suspected when an animal in an endemic is 
febrile, anaemic and in poor condition (Blood et al., 1989). The clinical 
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picture depends to some extent to the species of infecting trypanosomes and 
the susceptibility of the host. Diagnosis of the disease based on clinical 
manifestation is complicated because the disease may have acute, chronic or 
sub-clinical form. Conformation depends on the demonstration of the 
organism in the blood or lymph nodes smears using the parasitological 
methods available. 
1.9.2 Parasitological methods: 
The conventional techniques of microscopic examination for the presence of 
trypanosomes are still widely used, but newer and far more sensitive 
methods are beginning to supplant them. 
1.9.2.1 Blood films: the phases of infection, especially with T.vivax and 
T.congolense, the parasite can readily be observed by microscopic 
examination of a wet-mount of blood slides. This method is relatively less 
sensitive, with a detection limit of about 8.3 x 10³ trypanosomes per ml of 
blood (Paris et al., 1982). A drop of fresh blood taken from the ear vein of 
an animal with microscope slide and covered with a glass slip. This 
preparation is examined microscopically with light or phase contrast 
microscope at 400x magnification. From the relative size and movement 
pattern of the parasite, it is possible to guess on the species of the parasites 
involved, to be confirmed by stained preparation. 
Thin and thick blood smears fixed in methanol or acetone and stained with 
Giemsa may be used in the laboratory to detect blood parasites and 
determined the trypanosomes species involved, respectively. Stained lymph 
node smears are a very good method for diagnosis, especially for T.vivax 
and T.brucei. In chronic T.congolense infection, the parasites localize in the 
microcirculation of the lymph nodes and in other capillary beds, allowing 
diagnosis by examination of lymph node smears or smear made from blood 
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collected from the ear. These techniques are not sensitive enough to detect 
low parasite levels, characteristic of the disease in large animals at the 
chronic stage (Woo, 1970; Murray et al., 1977), and as a result, several 
techniques for the concentration of blood trypanosomes have been 
developed, which increase the chance of trypanosome detection. 
1.9.2.2 Concentration technique: Woo (1970) described a practical method 
using centrifugation of microhaematocrit capillary tubes containing the 
blood sample and examination of the buffy coat/plasma junction under the 
microscope. This method, known as haematocrit centrifugation technique 
(HCT), was subsequently improved in the buffy coat technique (BCT) by 
cutting the capillary tube, expressing the buffy coat /plasma interface on a 
microscope slide and using dark-ground or phase contrast illumination 
(Murray et al., 1977). The advantage  of these methods are that diagnostic 
sensitivity is increased due to a concentration of parasites following 
centrifugation, and that at the same time the packed cell volume (PCV) can 
be determined as a measure of anaemia. 
Another method available that is not common use as a flied diagnostic 
technique is the miniature anion exchange centrifugation technique (m-
AECT) described by Lumsden et al., (1979). This method use miniature 
anion-exchange columns for the separation of trypanosomes from 
erythrocytes prior to concentration by centrifugation. 
1.9.3 Serological tests 
1.9.3.1 Immunoflourescent antibody test (IFAT): The IFAT developed for 
trypanosomosis (Bailey et al., 1967) uses known trypanosome antigens to 
coat glass slides or microtitre plate wells. Blood samples to be tested are 
added to the wells and incubated and then conjugate is added. After 
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washing, the wells are examined with a fluorescence microscope. Apple 
green fluorescence occurs with positive blood samples. 
1.9.3.2 Card agglutination test for trypanosomes (CATT): The CATT test for 
human trypanosomosis relies on the agglutination of formalin-fixed, stained 
and freeze dried trypanosomes by antibodies in the patients' serum. 
The major antigen contributing to the test is the variant surface glycoprotein 
(VSG). 
1.9.3.3 Enzyme-linked immunosorbent assay (ELISA)  
1.9.3.3.1 Antibody ELISA: antigens are adsorbed on to micro-ELISA plate 
wells; in the presence of an enzyme-conjugated antiglobulin, the test serum 
reacts after incubation to give a chromogen-mediated colour change 
normally read with an ELISA reader. The test does not distinguish between 
current and previous infections as circulating antibodies remain in the host 
for some time after an infection is cured. 
1.9.3.3.2 Antigen ELISA: In an attempt to identify current trypanosome 
infections more accurately, tests were developed to detect circulating 
antigens released by parasites in the blood of infected animals (Nantulya, 
1990), an ELISA plate is coated with monoclonal species-specific antibodies 
and then test serum is added. The coating antibody captured the antigen in 
the serum. A second enzyme-labeled antibody is then added which binds to 
free combining sites of the captured antigen. Excess labeled antibody is then 
washed off and the reaction is revealed by addition of a substrate and 
chromogen. 
1.9.3.4 Latex agglutination antigen test: The principle of the test is that latex 
particles are sensitized with species-or subgenus-specific anti-trypanosome 
antibodies. If the relevant antigens are present in whole blood, plasma or 
serum, the antibodies capture the antigens. As there are several combining 
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sites on the antigen molecules, aggregates form, which can be detected as an 
agglutination reaction. This test is simple to use under field conditions 
(Leak, 1998). 
1.9.4 Parasite DNA detection technique 
Techniques in molecular biology have led to the development of DNA-based 
assay for detection of trypanosomal DNA. Species-specific DNA probes 
have been shown to detect simultaneous infection of cattle with T.vivax, 
T.b.brucei and T.congolense when conventional methods revealed only 
single infection (Nyeko et al., 1990). Consequently, PCR coupled with DNA 
probe hybridization could prove to be a highly sensitive tool for the 
diagnosis and assessment of therapeutic efficiency and disease progress 
especially in chronic trypanosomosis (Clausen et al., 1999). While PCR is a 
method of choice for the detection of African trypanosomes in both humans 
and animals, the expense of this method negates its use as a diagnostic 
method for the detection of endemic trypanosomosis in African countries 
(Kuboki et al., 2003).  
    
1.10 Control: 
Effective animal production is dependent on the prevention and or control of 
detrimental diseases including trypanosomosis (Sekoni, 1991). The livestock 
industry in Africa has also depended heavily on antitrypanosomal drugs for 
both prevention and treatment of trypanosomosis (ILRAD, 1990). 
Control of animal trypanosomosis can be based on: 
1. Use of innate resistance of the host to the effect of the infection 
(Trypanotolerance) 
2. Vector control 
3. Control of the trypanosome 
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4. Vaccination.  
1.10.1 Trypanotolerance 
In many species of livestock, especially exotic breeds, trypanosomosis is a 
severe disease that often terminates in death of the animals. In wild Bovidae, 
however, the disease course is different, these animal have a remarkable 
degree of resistance to trypanosomosis probably as a result of natural 
selection of pressure. These animals do get infected but they do not develop 
clinical disease. Recent investigations have shown that the increased 
resistance of wild animals to the ill-effect of trypanosomes infection may be 
related to their innate ability to control the levels of parasitaemia (Murray et 
al., 1982). Certain indigenous breeds of cattle In West and Central Africa 
can also better tolerate exposure of trypanosomosis (Murray et al., 1982). 
There is also evidence for similar breeds in East Africa e.g. Orma Boran 
(Njogu et al., 1985). These naturally resistant (Trypanotolerant) livestock 
breeds offer a potential means for improving agricultural productivity in 
tsetse-infested areas of Africa. It has been shown, both in field and 
experimentally, that Trypanotolerant cattle are capable to varying extent, of 
resisting the pathogenic effect of trypanosomosis (Murray et al., 1982); they 
remain productive despite of the infection and often spontaneously recover 
from infections (Nantuilya et al., 1984; Nantuilya, 1986). There is another 
breed of cattle from West Africa, the N'Dama which is known to be 
naturally resistant to the effect of trypanosomosis (Paling et el., 1987). Even 
under field conditions, trypanotolerant livestock can be productive under 
trypanosome challenge depending on nutrition status (ILCA, 1979). 
1.10.2 Vector control:  
Tsetse vector control methods relying on large-scale bush clearing and aerial 
spraying methods are no longer used due to environmental concerns. Tsetse 
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control currently relies on two bait systems: insecticide-treated traps, targets, 
and insecticide treated livestock. Sterile Insect Technique (SIT) has also 
been used in efforts to eradicate tsetse flies in some areas. Because of the 
stability of tsetse populations and their low reproductive rate, little sustained 
mortality pressure (additional to natural mortality) needs to be exerted on a 
population to cause its extinction (Weidhaas & Haile 1978).That makes 
them good candidates for traps and target control methods. Not to be 
forgotten though are the risk of reinvasion or immigration into an area 
already cleared of tsetse flies. The theory behind this control method is 
simple: the flies are visibly attracted to a trap or target. This attraction may 
be further helped by the use of olfactory attractants. When the tsetse lands 
on a trap or target, they either receive a lethal dose of insecticide, or are 
caught in the trap and subsequently die (Leak, 1998). The effectiveness of 
traps and targets will depend on when the flies are active, how they move in 
their active state, whether they will move into the vicinity of a trap or target 
and finally, whether they are trapped or killed (Williams et al., 1992). 
Insecticide-treated livestock was developed as a method of tsetse control 
from the concept of baited traps and targets (Baylis & Stevenson 1997). It is 
widely accepted by a majority of stockowners in Africa. The method has 
been used to control tsetse and trypanosomosis with varying results in Kenya 
(Stevenson et al., 1991). Most commonly used are the synthetic pyrethroids, 
and of these deltamethrin appears to be the most potent and it is also of low 
mammalian toxicity and has minimal environmental impact (Thompson et 
al., 1991). Extensive use of insecticides on cattle for tsetse control appears to 
have the potential to interfere with endemic stability/immunity of cattle to 
several tick borne diseases. Thus, the long-term use of these products may 
jeopardize control of tick borne diseases (FAO, 2001). 
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1.10.3 Control of trypanosome: 
1.10.3.1 Chemotherapy   
Chemotherapy is the treatment of disease by use chemical drugs. Such drugs 
are curative. They disrupt or block one of the vital processes, which essential 
to invading microorganism. Certain compounds have specific effect on some 
enzyme system, or block essential metabolic pathways, but the exact way in 
which they work is often not known or only incompletely understood, and 
this is true for most of the trypanocides (chemotherapeutic drugs that kill 
trypanosomes or inhibit their development). The application of 
antitrypoanosomal drugs has been the mainstay of controlling animal 
trypanosomosis since the early 1950s (Kinabo, 1993). It is important to 
realize that drugs alone will not cure trypanosomosis. Trypanosomes 
overwhelm the immune system of the host, they are immunosuppressive. 
Chemotherapy, by stopping the multiplication of the trypanosomes, helps the 
immune system to overcome the infection. The infection will not be 
effective in well-fed and rested animals, in which the immune system is not 
adversely affected by stress and lack of food (Geerts & Holmes, 1997). 
Trypanocidal drugs remain widely available and affordable for farmers (at 
approximately US$1 per treatment). They are often the first drugs tried by 
farmers when their cattle develop symptoms of the disease (Geerts et al., 
2001).  Consequently treatment given by livestock owners is not without 
serious drawbacks because most farmers do not have adequate knowledge 
on diagnosis and the appropriate drug to use even in areas of high prevalence 
of trypanosomosis; and because trypanocides are frequently used in the 
absence of diagnosis or used to treat conditions for which they are not 
effective (Holmes et al., 2004). However, used properly, veterinary drugs 
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permit higher levels of production, improve animal welfare and safeguard 
the livelihood assets on which 700 millions poor farmers in developing 
countries rely. Used improperly, veterinary drugs waste scarce resources, 
occasion avoidable sickness and death, mask poor production and promote 
drug resistance leading to exacerbated disease in animals and humans 
(Grace, 2005). Trypanocidal drugs are the most widely applied method that 
farmers use to treat and prevent trypanosomosis in sub-Saharan Africa. It 
has been estimated that about 35 million doses of trypanocides are 
administered each year to an approximately 45 - 60 million cattle at-risk of 
trypanosomosis (Kristjanson et al., 1999; Sones, 2001). Trypanocides are 
popular because farmers can directly treat and, if successful, cure their own 
animals without relying on the efforts of others. All these drugs have been 
on the market for over 40 years and several generic forms of them from a 
wide range of companies have become available on the African market 
(Holmes et al., 2004). 
 The treatment of African animal trypanosomosis at farmer's level has been 
predominantly dependent on the use of the trypanocidal drugs (diminazine, 
homidium salts and isometamidium) it is estimated that about 35 million 
doses per year are used in Africa to cure the disease (Geerts & Holmes, 
1997). There is another problem in the treatment of animal trypanosomosis, 
because of the variety of domestic livestock that are susceptible to 
trypanosome infection and the diversity of the trypanosome species that are 
pathogenic to animals of economic importance, the problem of 
chemotherapy and chemoprophylaxis are even more complicated and 
formidable than in Human trypanosomosis (Mulligan, 1970). Other 
complementary measures aimed at tsetse eradication using insecticide were 
successful only to a limited extent. Despite the fact that chemotherapy is the 
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major mean of disease control, development of new antitrypanosomal drugs 
have been more or less static over the last three decades, due to lack of 
interest by the pharmaceutical industry to invest into research and 
development of antitrypanosomal drugs (Gutteridge, 1985). Consequently, 
this has been a major stimulus to intensive research into the few existing 
drugs. It is well known that developing and effective drug for chemotherapy 
of protozoan infections and particularly effective against Trypanosoma 
brucei evansi, is a difficult task (Bourdichon & Zhang, 1999). T. evansi is an 
economically important infection in a variety of domestic animals such as 
horses, cattle (Lun et al., 1993). Many drugs are used for treatment of 
trypanosomosis: Isometamidium, Suramin, Diminazine aceturate, 
Quinapyramine and Ethidium (Leach & Roberts, 1981) and Cymalersan 
which was developed in 1980s (Luckins, 1999). 
1.10.3.1.1 Isometamidium:-  
Isometamidium (Samrin ®, Trypidium ®) is phenanthridinium compound. 
Its antitrypanosomal activity was first demonstrated more than 60 years ago 
(Browning et al., 1983). It is described chemically as 7 – (m – 
amidinophenyldiazo – amino) – 2 – 10 – ethyle – 9 – phenyl – 
phenanthridinium (C28H25CN7HCl: molecular weight 531.5). It is active 
against T.congolense, T.vivax, T.brucei and T.evansi infection in donkeys, 
horses and camels (Kinabo, 1993). Isometamidium chloride has been used 
for the control of trypanosomosis in animals for over 36 years, but recently 
there have been reports of prophylaxis failure under natural conditions 
(Wesongah et al., 2004). Isometamidium is used mainly in the prevention of 
tsetse-transmitted trypanosomosis. Its usefulness in the treatment of T.evansi 
infections is not clear (Dieleman, 1986). Additional research suggested that 
T.evansi might be innately resistant to this compound (Brun & Lun, 1994). 
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  It is routinely administrated intra-muscularly at doses of 0.25 – 0.5 mg/Kg 
for therapeutic purposes and 0.5 – 1.0 mg/Kg for prophylactic purposes 
(Kinabo, 1993). The acute toxic effects of it have been reviewed in dogs, 
cattle, camels and goats (Kinabo & Bougan, 1988). 
1.10.3.1.2 Suramin:  
Suramin is a hexasulfonated naphthylurea commonly used as 
antitrypanosomal drug and more recently for the treatment of malignant 
tumours (Monteiro et al., 2004). 
It is hexa – sodium – 3. – Ureylene – bis (8 – (3 – benzamido – p – toluido) 
– 3.5 Ureylene Sulphonate). (C15H34N6Na6O23S6, molecular weight 1429). 
It's generally considered as the drug of choice for the early stages of African 
human trypanosomosis (sleeping sickness) especially T.rhodesiense 
infections (Kinabo, 1993). It's also the drug of choice for the adult forms of 
the filarial parasite Onchocerca volvulus. In domestic animals, Suramin has 
been used primarily as a curative drug against T.evansi infections in camels, 
and   T. evansi and T.equiperdum infection in equine (Kinabo, 1993).  
Calorimetric studies revealed two distinct binding sites for suramin in α -
thrombin. In addition, circular dichroism studies showed that suramin causes 
significant changes in α -thrombin tertiary structure, without affecting the 
secondary structure content. Interaction with α -thrombin resulted in an 
increased fluorescence emission of the drug. Complex formation was 
strongly affected by high ionic strength suggesting the involvement of 
electrostatic interactions. However, part of the biological activities of 
suramin might be related to α -thrombin inhibition at extra-vascular sites 
(Monteiro et al., 2004). 
The standard therapeutic doses are 7 – 2ml/Kg in horses and 8 – 12 mg/Kg 
in camels using 10% aqueous solution given intravenous. For prophylactic 
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purposes, doses 1 – 2 g repeated at 10 days intervals are recommended 
(Kinabo, 1993). 
1.10.3.1.3 Diminazine aceturate: 
 Diminazine aceturate (Baranil ®) compound consist of two amidinophenyl 
moieties joined by a trizene bridge: P, P – diamidino diazoaminobenzene 
diaceturate tetrahydrate; N – diamidinophenyltriazene diaceturate 
tetrahydrate; (C22H24N4O6.4H2O molecular weight 587.6). Baranil is an 
odourless yellow powder. A dose of 7 mg/kg was sufficient to cure 
infections of with T. vivax and T.congolense, whilst 2ml/kg body weight was 
required for infections with T.b.brucei. In the treatment of T.b.evansi 
infections. Baranil produces clinical improvement in equines, pigs and dogs. 
In mice Baranil produces complete clinical cure as well as in buffaloes. In 
camels, it is contra – indicated because it can produce severe side effects and 
even death (Leach, 1961). Recent studies in horses indicate that the 
treatment is not always successful in this species (Tuntasuvan et al., 2003). 
 It is normally injected intramuscularly, and some swelling may occur after 
subcutaneous administration. It is not normally used in horses, because even 
after intramuscular injection the reaction is sometimes severe. Toxicity and 
even death has been reported in camels, donkeys and dogs treated at 
recommended dosage (Uilenberg, 1998). 
1.10.3.1.4 Cymelarsan: 
Melarsomine (Cymelarsan®) is the most recent drug developed and has 
proven to be highly efficacious in treatment of T. evansi infected camels 
(Zelleke et al., 1989 and Youssif et al., 2007). 
Cymelarsan ® (Mel cy) is an arsenical drug, related to melarsen (which used 
in human sleeping sickness). It is described chemically as; bis 
(aminoethylthio – 4 melamino phenyl arsine dihydroxychloride). The name 
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Mel cy is derived from the chemical formula Melarsen oxide, with 
cysteamine as a lateral chain. CymelarsanR is fully effective against T.evansi 
and T.brucei strains that are resistant to other drugs commonly used in the 
field, Quinapyramine and Suramin (Raynaud, et al., 1989b). Mel cy is 
administrated preferably intramuscularly, but the subcutaneous route is also 
possible. There are often transient local and systemic reactions. The dosage 
originally recommended by the manufacturer for camel surra is 0.25mg/kg 
body weight and has proved to be too low in other animals and even for 
camels a dose of 0.5mg/kg body weight may be more realistic. Mel cy so far 
appears to have been registered only for use in camels. CymalersanR inhibits 
the metabolism of the cell by inhibition of trypanothion reductase (TTR), an 
enzyme that is present in the parasite and absent from the host, (Bujon, 
1990).     
1.10.3.1.5 Quinapyramine: 
 Quinapyramine is anti – trypanosomal drug that was introduced in the 
1950s for field use as a therapeutic (Antrycide Sulphate ®) and prophylactic 
drug (Antrycide prosalt ®) for animal trypanosomosis. It is 4 – amino – 6 (2 
– amino – 6 methylquinoline – 1,1dimetho (methyl Sulphate) 
(C19H28N6O6S2, molecular weight 532.6). (Curd & Davey, 1950). It has been 
used successfully against T. congolese T. vivax and T. brucei infection in 
cattle (Leach & Roberts, 1981), sheep and goat. Infections of T.evansi, 
T.equimum and T.equiperdum have also been treated effectively using 
quinapyramine (Leach & Roberts, 1981) and in fact, it has generally been 
considered the drug of choice for these infections. Severe and immediate 
general reaction resulting in collapse is of common occurrence when the 
drug is administrated to horses; these symptoms usually subside after a short 
time but are sometimes fatal (Mulligan, 1970). It advisable to have a suitable 
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antidote at hand and to divide the amount of the drug given in two or three 
equal doses administrated at six hourly intervals subcutaneously; if 
administrated at different sites this will also reduce the tendency to abscess 
formation at the injection site. Quite severe and sometimes fatal general 
reaction may some times be seen in dogs with doses in excess of 4.5mg/kg 
(Mulligan, 1970). However, due to development of drug resistance, the drug 
was withdrawn from the markets in many parts of Africa in the 1970s, 
because at that time it had been found to cause serious drug resistance 
problems in cattle trypanosomosis in African (Uilenberg, 1998). 
1.10.3.1.6 Ethidium: 
Ethidium bromide (Homidium bromide) is (3.8diamino – ethyl – 6 phenyl – 
phenanthridium promide). It is a dark purple, almost odourless crystalline or 
amorphous powder with a persistent bitter taste. Solution is stable for several 
days at 20°C. Ethidium bromide is readily soluble only in hot or boiling 
water, but this practical disadvantage was overcome by use of the chloride 
(Novidium ®) which is soluble in cold water. Based on trials in Sudan, 
Kenya, Tanganyika and Nigeria against variety strains of T.congolense and 
T.vivax, a therapeutic dose of 1.0mg/kg was recommended (Leach & 
Roberts, 1981). Intramuscular injection was advised by the manufacturers in 
order to reduce the local reaction that can occur at this dose given 
subcutaneously, because Ethidium has dermonecrotic properties; it is 
inactive after oral administration to rats (Bailey, 1967). Ethidium has been 
used primarily as a curative drug in cattle. A large scale investigation of 
block – treatment (1mg/kg) of 11,200 head of cattle in 200 herds in Uganda 
(Mwambu, 1967) showed that these cattle, which were no longer responding 
to Antrycide curative treatment, improved in the two of the three month after 
Ethidium treatment; the previous infection rate (up to 33%) was much 
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reduced, feeding, and milk yield were improved, and no clinical cases or 
death from trypanosomosis occurred. A selective effect on T. vivax was 
noted, as infection was predominant in cattle before Ethidium treatment, but 
relapses were mainly to T.congolese. Ethidium is not curative for T.vivax 
infection (Stephen & Mackenzie, 1959). Extensive use in cattle rapidly led 
to appearance of Ethidium resistant strains, especially of T.congolense in 
west and east Africa. Homidium was extensively used in the 1960s and 
1970s but its usefulness has been greatly reduced due to wide spread 
resistance over the years (Scott & Pegram, 1974). It has remained essentially 
a curative drug in the field despite claims that the drug has prophylactic 
properties (Dolan et al., 1990). More recently, De Deken et al., (1989) has 
reported success in protecting rabbits for more than 300 days against seven 
challenges of T.congolense using a slow release devise implanted 
subcutaneously. This finding suggests that the commonly used drug product, 
Novidium ® lack prolonged prophylactic activity because the active 
principle, Homodium is rapidly eliminated from the body.  Should this slow 
release devise technology prove cost-effective in the field it will 
undoubtedly be widely accepted in many areas with an yearlong high 
incidence of trypanosomosis (Kinabo, 1993). In a field trial carried out in 
South West Kenya over a twelve month period, which included several 
months of high trypanosome challenge, the average period of protection 
reported for Ethidium was 4 – 6 weeks (Stevenson, et al., 1995). Severe 
general reaction was only occasionally seen in horses. The drug may cause 
local reaction and should be administrated by deep intramuscular injection 
taking care to avoid leakage into subcutaneous tissues. Dividing the dose 
between two sites may reduce local reactions in the horse. After some years 
of mass field therapy of cattle infected with T.congolense resistance to the 
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normal curative dose of 1 mg/Kg may become widespread, but resistant 
strains of T.vivax, though they may occur (Stephen, 1963) are evidently 
much less frequent in northern Nigeria (Jones – Davies & Folkers, 1966; 
Williamson & Stephen 1960). 
1.10.3.2 Chemoprophylaxis 
Chemoprophylaxis or chemoprevention, is the prevention of disease by use 
of chemical drugs, logically this implies a residual effect, as prevention 
depends on the persistence of the drug in the system of the animal. A 
chemoprophylactic drug is also curative, but a curative drug is not 
necessarily prophylactic. There is no essential difference between the two 
categories of drugs; drugs that can be used for chemoprophylaxis just persist 
longer. Preventive drugs are administrated at defined intervals, and care 
must be taken not to administer them more frequently than prescribed. Often 
a depot of the drug is formed at the site of the injection where it s retained 
and slowly released into the circulation to maintain the concentration in the 
blood at a level at which no trypanosome can exist. Other drugs are not 
maintained in the form of such a local depot, but are found loosely attached 
to blood proteins and become slowly available to act on the parasite. There 
is another way to create a drug depot, even if the drug is normally only 
curative, by incorporating, it into a suitable support. After subcutaneous 
implantation, the drug will be gradually released, so that an adequate 
prophylactic (and curative) level is maintained in the blood and tissue fluid.  
1.10.3.3 Drug resistance 
Drug resistance is the heritable loss of sensitivity of a microorganism to a 
drug to which it was before sensitive. Information on the extent and 
significance of the problem of drug resistance is still scanty (Sinyangwe et 
al., 2004). Drug resistance is known in many pathogenic organisms, as well 
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as in larger parasites. It can be catastrophic where an animal (or human) 
population has become too dependent on the regular administration of a 
certain compound, with no other active treatment available. Prolonged, 
regular use of drugs apparently inevitably leads at the end to the 
development of resistance by the microorganism or parasite in question 
(Uilenbereg, 1998). Drug resistance in trypanosomosis can be defined as the 
ability of trypanosomes strains to survive, despite the administration of 
antitrypoanosomal drug given in doses equal to or higher than those usually 
recommended. Drug resistance is one of the very important explanation for 
the failure of treatment with trypanocides in the field. For a more efficient 
and economic control of trypanosomosis by means of chemotherapy a better 
surveillance for the drug resistance is required. 
Drug resistance was found to develop, when trypanosomes were exposed to 
sub-curative doses of trypanocides (El Rayah & El Malik, 1990) and is also 
related to the general prophylactic use of the drug.  
The exposure of trypanosomes to subtherapeutic concentrations of 
trypanocidal drugs, the treatment frequency and the degree of drug exposure 
of the parasite population are important factors influencing the development 
of drug resistance (Geerts & Holmes 1998). Furthermore, some trypanocidal 
drugs, such as ethidium, are well-known mutagenic compounds and might 
induce mutations, the most resistant of which might be selected under drug 
pressure (Holmes et al., 2004). The phenomenon of cross-resistance has now 
been clearly demonstrated. Quinapyramine usage has been shown to induce 
resistance to isometamidium, homidium and diminazene (Ndoutamia et al., 
1993). 
Currently, resistance to trypanocides has been reported from 15 countries in 
Africa (Geerts & Holmes, 1998; Diall et al., 2003). Resistance to 
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diminazene and isometamidium has been reported by several authors 
(Authié, 1984; Chitambo & Arakawa, 1991; Peregrine et al., 1991; Clausen 
et al., 1992; Codjia et al., 1993; Mulugeta et al., 1997; McDermott et al., 
2003; Sinyangwe et al., 2004). Homidium that was previously used 
extensively as a prophylactic drug was also rendered almost useless by the 
widespread development of resistant trypanosome strains (Clausen et al., 
1992). In addition, the occurrence of multiple drug resistance to diminazene, 
isometamidium and homidium has been reported in trypanosome 
populations in five countries, namely Nigeria (Ilemobade, 1979), Kenya 
(Gitatha, 1979), Burkina Faso (Clausen et al., 1992), Sudan (Mohamed-
Ahmed et al., 1992) and Ethiopia (Mulugeta et al., 1997). Recent reports 
show increasing resistance to trypanocides in Burkina Faso and Mali (Grace 
2005; McDermott et al., 2003). Other African countries with reported cases 
of drug resistance include Chad, Uganda, Zimbabwe, Tanzania, Côte 
d’ivoire, Somalia, Zambia, Central African Republic (Finelle & Yvore, 
1962) and Mozambique (Jamal et al., 2005).  
Today chemo-resistance was reported against most trypanocidal drugs used 
(Williamson et al., 1982). The development of resistance to one compound 
was often accompanied by cross-resistance to other trypanocides. 
1.10.3.4 Combination chemotherapy possibilities  
Some infectious diseases are routinely treated with drug combinations 
(Keiser et al., 2001). The lack of good alternatives for treatment of African 
trypanosomosis led numerous investigations to study the potential synergy 
of active compounds. Many studies investigated the susceptibility of 
Trypanosma brucei brucei infections to Diminazine aceturate in 
combination therapy with non-steroidal anti-inflammatory drugs (NSAIDs) 
and Lithium chloride (Odika et al., 1995; Abatan, 1991). The effect of 
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combinations of Ca+2 antagonists with standard trypanocidal against 
T.evansi was recently described (Anene et al., 1996). Development of 
hypersensitivity in drug resistant strains seems to correlate with synergism 
between the drugs to which the strain is hypersensitive (Williamson, 1975). 
Drug synergy may have various causes other than the well known 
"sequential blockage" of different enzymes on the same metabolic sequence 
(which may in some cases produce antagonism or additive effect only) 
(Griendey et al., 1975). One drug may damage a macromolecule and the 
other inhibits the availability of precursor for its synthesis (a diamidine plus 
cordycepin). A drug affecting membrane permeability may allow increased 
access of a second of different type (the trypanocidal polyene amphotercin B 
plus any standard trypanocide). Drugs, which bind to DNA, would be 
expected to be synergetic. The demonstration that many specific inhibitors 
of RNA synthesis are powerfully trypanocidal (Williamson & Scottfinnigan, 
1975) may indicate potential source of ancillary agents, which, if not too 
toxic, might be used to reinforce existing drugs.  
Complexes of suramin with cationic drugs especially quinapyramine have 
been found to be more effective in prophylaxis than suramin alone but such 
complexes have not been widely acceptable for field use because of the high 
cost of the complex formulations and the severe tissue reaction that occur in 
the injection sites (Williamson, 1970 and Williamson et al., 1982). It is 
unclear weather the improved prophylactic activity is due to 
pharmacodynamic or pharmacokinetic factors. Suramin has been shown to 
be synergistic with a number of drugs, including Tryparsamide, Puromycin, 
and Diminazine (Williamson et al., 1982). More studies on the synergistic 
activity seem justified considering the potential of such drug combinations 
for clinical use in the field (Kinabo, 1993).                                      
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1.10.4 Vaccination 
Attempts to vaccinate cattle against trypanosomosis started at an early stage 
in trypanosomosis research. Bevan (1928) for example tried to protect the 
animals by deliberately infecting them with known strains of trypanosomes 
and then treating them at various intervals following infection. These 
animals were said to be tolerant or to some extent “premunized“but the 
resistance broke down relatively easy. Attempts were also made to vaccinate 
cattle with killed trypanosomes by giving part-curative doses of trypanocidal 
drugs after infection, or by injection of small numbers of living 
trypanosomes. 
 
 1.11 Herbal treatment: 
Herbal treatment of various diseases in human and veterinary medicine is 
common practice in Sudan and many other countries centauries ago. 
Because of the drug resistance, side effect, relapse and expensive costs, 
phytotherapy is therefore being resorted to in developing countries, owing to 
the low price and easy accessibility. It would thus be worthwhile to pay 
attention to the therapeutic remedies that are being used by herdsmen to 
combat trypanosomosis traditionally. Some herbs have been used for 
veterinary purposes, and some diseases peculiar to animals had been treated 
with such herbs (Nwude & Ibrahim, 1980).  Plants have historically been 
among the common source of medicaments, either processed as traditional 
preparations, or used to prepare pure active principles pharmaceutically. In 
Africa traditional medicine, in the sense of herbal treatment, has wide use 
and still holds a strong position in medicinal care (Feierman, 1981). Many 
natural products of plant origin, with a wide range of different chemical 
structure, have been reported to have activities against different species of 
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protozoan parasites including Plasmodium, Trypanosoma, Leishmania and 
Entamoeba (Barbara, 1998). Although many natural products have shown 
antiprotozoal activity (usually in vitro), only a few have found a place in 
therapeutics. A major problem in discovering new antiprotozoal drugs is that 
protozoa, unlike pathogenic bacteria, share many common biochemical ways 
with the animal host. Therefore, antiprotozoal activity without sufficient 
selectivity to kill the parasite only and not damaging the animal host is of 
limited value to drug development (Barbara, 1998).  
Generally, some common problems have to be kept in mind while working 
with the antiparasitic plants: 
i. Highly therapeutic efficacy is often associated with a 
concomitant high toxicity. 
ii. Active compounds in vitro do not necessarily display activity 
in rodent models i.e. in vivo. 
iii. Crude extracts are often more active than purified compounds 
indicating synergetic activity of different components (Kirby, 
1996). 
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CHAPTER TWO 
MATERIALAS AND METHODS 
2.1The animals  
Outbred albino rats (Albino Wister) of both sexes were used. 
2.2 Adaptation period  
Two hundred and ninety rats (290), 120 – 150gm of both sexes were 
purchased from the Medicinal and Aromatic Plant Research Institute 
(MAPRI) – National Center for Research. Animals were housed in 
laboratory cages at The General Criminal Directorate laboratories – Burri- 
and at the College of Veterinary medicine – University of Khartoum - 
Shambat.  Animals were fed daily on cooked meal composed of meat, liver, 
wheat, multivitamins, and with free access to water. 
The rats were kept for 15 days before commencement of the study to 
acclimatize. Twenty rats were selected randomly, divided into two equal 
groups; Uninfected- untreated (control negative group), and infected-
untreated (control positive group). The remaining animals were infected 
with T. evansi and were used in twenty seven experiments each experiment 
was divided into groups; each group consisted of 10 rats. 
2.3 Infection 
The parasite (Trypanosoma evansi) was isolated from naturally infected 
camels from Eastern Sudan and propagated in albino rats.  
 
 2.4 Parasite counting  
The rapid matching wet-count technique described by Herbert and Lumsden, 
(1976) was used. This entailed examining a drop of rat blood under the X 40 
objective and X 10 eye pice magnification of a microscope and counting the 
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number of trypanosomes in each field. This was explorated to number of 
parasites/ml 
 
2.5. Plant material 
The three tested plants in the present study were selected based on 
information from traditional healers on their curative effect in the treatment 
of blood parasites and symptomatic effects. 
2.5.1 Erythrina abyssinica DC., subsp. Abysssinica, Prodr. 2: 413 (1825) 
Synonym: E. tmentosa (Hotchs.) R.Br. ex A.Rich., Tent Fl. Abyss. 1:213 
(1847). 
Vernacular names: (Fung) Korag. Danab Alkalib.  
Family: Papilionaceae (Fabaceae) 
Trees, up to 15m high. Barks yellow-brown, thick, rocky, deeply fissured, 
often armed with blunt woody prickles; branchlets armed with strong 
recurved prickles, densely tomentose when youg. Leaves compound, of 
three leaflets; leaflets broadly ovate to rhomboid, when mature glabrous 
above, densely and shortly tomentose beneath, c. 13 X 12.4cm. 
Inflorescences up to 15cm long, appearing when the tree is leafless. Fruits 
pods, up to 12.5cm, velvety-pubescent, woody moniliform; seeds vermilion 
and black, very shiny. 
Found in: Golo, Ingassana, Blue Nile state. 
Chemical Constituents: Flavinoids, Isoquinoline alkaloids, Indole alkaloids 
and Protied "Trypsin inhibitor" were isolated from different plant organs. 
Folk-uses: The maceration of the bark is used against jaundice in man 
(ElGhazali et al., 2003).  
2.5.2 Tinospora bakis (A. Rich.) Miers. In Hook., Niger Fl.:215 (1849). 
Synonym: Cocculus bakis A.Rich., Fl. Seneg. Tent. 1:12,t. 4 (1831). 
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Vernacular names: (Fung) Mama, (Ar.) Irg al-hagar.  
Family: Menispermaceae 
Slender glabrous lianes. Branchlets with lenticels. Leaves broadly ovate-
triangular, 5-8 cm. across, thinly papery, glabrous, and digitately 7-nerved at 
base, petiole 2.5-8.0 cm long slender. Male inflorescences axillary racemose, 
slender, up to 8 cm long; female inflorescences up to 12 cm long. Fruits 
drupes, c. 6-9 X 4-5 mm. 
Found in: Komul, Ingassana, Blue Nile state 
Chemical constituents: Palamtine isoquinoline alkaloid was isolated. 
Folk-uses: the maceration of the roots are used for headache (ElGhazali et 
al., 2003).  
2.5.3 Polygala erioptera DC., Prodr. 1: 326 (1824). 
Synonym: P. triflora, var. diffusa Oliv., F.T.A. 1: 128 (1868); P.erioptera, 
var. angolensis Chod, in Mem Soc. Phys. Geneve, 31 (2): 344 (1893). 
Vernacular names: Irq Algabal Alaswad. 
Family: Polygalaceae. 
Erector or diffused annual herbs, up to 30 cm high. Stem and leaves grey-
pubescent. Leaves alternate, linear-lanceolate, midrib prominent at the lower 
surface, up to 3 cm long. Flowers solitary at the internodes, pubescent, with 
three small bracts at the base of pedicel; calyx with two with two winged 
sepals; corollas pink. Fruits capsules, ciliate, c. 4 mm long. 
Found in: Bau, Ingassana, Blue Nile state 
Chemical constituents: Triterpinoidal saponin was isolated. 
Folk-uses: the maceration of the roots are used for headache (ElGhazali et 
al., 2003).  
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2.6 Preparation of plant extract: 
The water, methanolic and chloroformic extracts were obtained from 
Erythrina abyssinica, Tinospora bakis and Polygala erioptera. The plants 
were dried and grounded into powder; extracts were made with water, 
methanol and chloroformic as follows: 
2.6.1 Water extract  
100 g of the powder was dissolved in 400 ml of water. The filtrate obtained 
was concentrated on a water bath at 50 ْC. 
 
2.6.2 Methanolic extract  
Methanol extract was obtained by maceration of dried ground (20g) of plant 
with 200 ml of methanol at room temperature for 18h. The aqueous fraction 
was lyophilized to yield crude methanol extract. After percolation, this 
extract was mixed with 100 ml of H2O and methanol was evaporated in 
vacuo. 
 
2.6.3 Chloroformic extract  
 Plant (110 g) was extracted with cold chloroformic (CHCl3) for seven days. 
The CHCl3 extract was filtered and concentrated on a rotary evaporator in 
vacuo at 30 °C until dryness.  
 
 2.7 Experiment 
2.7.1 Experimental Design 
The experimental animals were divided into three main experimental 
treatments: 
Uninfected- untreated negative control treatment. 
Infected- untreated positive control treatment. 
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Infected treatments and treated with the plants extracts as follows: 
1. Erythrina abyssinica treated groups: 
Group (1) each rat was treated with total dose 5ml of the water extract.              
Group (2) each rat was treated with total dose 3ml of the water extract. 
Group (3) each rat was treated with total dose 2ml of the water extract. 
Group (4) each rat was treated with total dose 5ml of methanolic extract. 
Group (5) each rat was treated with total dose 3ml of methanolic extract.               
 Group (6) each rat was treated with total dose 2ml of methanolic extract.  
Group (7) each rat was treated with total dose 5ml of chloroformic extract.  
Group (8) each rat was treated with total dose 3ml of chloroformic extract.  
Group (9) each rat was treated with total dose 2ml of chloroformic extract. 
 
2. Tinospora bakis treated groups: 
Group (1) each rat was treated with total dose 5ml of the water extract.              
Group (2) each rat was treated with total dose 3ml of the water extract. 
Group (3) each rat was treated with total dose 2ml of the water extract. 
Group (4) each rat was treated with total dose 5ml of methanolic extract. 
Group (5) each rat was treated with total dose 3ml of methanolic extract.               
 Group (6) each rat was treated with total dose 2ml of methanolic extract.  
Group (7) each rat was treated with total dose 5ml of chloroformic extract.  
Group (8) each rat was treated with total dose 3ml of chloroformic extract.  
Group (9) each rat was treated with total dose 2ml of chloroformic extract. 
 
3. Polygala erioptera treated groups: 
Group (1) each rat was treated with total dose 5ml of the water extract.              
Group (2) each rat was treated with total dose 3ml of the water extract. 
Group (3) each rat was treated with total dose 2ml of the water extract. 
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Group (4) each rat was treated with total dose 5ml of methanolic extract. 
Group (5) each rat was treated with total dose 3ml of methanolic extract.               
 Group (6) each rat was treated with total dose 2ml of methanolic extract.  
Group (7) each rat was treated with total dose 5ml of chloroformic extract.  
Group (8) each rat was treated with total dose 3ml of chloroformic extract.  
Group (9) each rat was treated with total dose 2ml of chloroformic extract. 
 
2.7.2 Experimental Inoculation: 
A sample of Trypanosoma evansi infected rat's blood was obtained from the 
retro-orbital vein in test tube containing Phosphate Buffered Seline Glucose 
(PSG, pH 8.0) using capillary tube. This was done to activate the 
trypanosomes. Each rat was inoculated intra-peritoneum (i.p) with blood of 
infected rats containing number of parasites explorated to 3-5 parasite/field. 
The negative control group was given PSG only.  
The treatment started when the parasite appeared in the peripheral 
circulation in each rat of the group. 
                                                                                                                    
2.7.3 Experimental treatment  
Each extract was administrated in three doses 5ml or 3ml or 2ml intra-
peritoneum (i.p). 
 
2.8 Detection of parasite (T.evansi): 
The parasitaemia was examined daily by screening wet blood smear 
obtained from the retro-orbital plexus by buffy coat technique (¾ of the 
capillaries tubes was filled with the blood, then centrifuged at 12.000 
round/minutes, then broken in slide,  read under X10).(Murray et al., 1977). 
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2.9 Haematological methods: 
Blood samples were collected from all animals for haematological and 
biocheminal examinations at the days 1, 4, 7, 10, 13, 16, 19, 26, 33, 40, 47 
of the experiment.   
2.9.1 Blood collection: 
Blood samples were withdrawn from the retro-orbital plexus of all rats 
before, after infection, and after treatment. To open the retro-orbital plexus 
capillary tube was used, the blood was allowed to drop in Bejo bottles 
coated with EDTA. Blood samples were divided into two portions: one 
portion was taken in plain tube and allowed to clot for serum separation 
while the other was collected in a tube containing ethylene diamine – tetra 
acetic acid (EDTA) as anticoagulant for haematology. 
2.9.2 Packed cell volume (PCV): 
Blood samples were drawn into capillary tubes, sealed at one end with 
cristaseal (Hawksley and Sons, Ltd, England) and centrifuged in a 
microcentrifuge for 5 min. The PCV percent was read in a Hawksley, 
microhaematocrit reader.  
2.9.3 Red blood cells (RBC) count: 
Erythrocytes (RBC) were counted in an improved Neubauer 
haemocytometer (Hawksley and Sons Ltd, England) using haymen's solution 
as a diluent consisting of 0.5g mercuric chloride, 0.5g sodium sulphate and 
1.0g sodium chloride made up to 200ml distilled water as described by Jain, 
(1986). 
2.9.4 Determinatiom of Haemoglobin (Hb) concentration:  
Hb was determined by cyanomethaemoglobin method (Jain, 1986). 0.25ml 
of blood EDTA was added to 5ml of Drakin's solution (0.2g potassium 
ferricynide + potassium cynide + sodium bicarbonate in 1000ml distelled 
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water) and allowed to react for 10 minutes. Then Drakin's solution was used 
as blank, the O.D of blood samples was read in using CIBA Corning 
colorimeter (Jenway-England). The result was exlporated from the O.D of 
samples was plloted in graph. The haemoglobin concentration was measured 
in gm/dl of blood. 
 
2.10 Biochemical methods: 
2.10.1 Determination of Serum billirubin 
Blank: distilled water 
Reagents: 
1. Diazo A 
1gm of Sulphanilic acid 
     15ml of Concentrated HCl 
     985ml of distilled H2O 
2.  Diazo B 
     0.5gm of Sodium Nitrite  
     100ml of distilled H2O 
Control: 1.8ml distilled H2O + 0.2ml control 
Test 1.8ml distilled H2O + 0.2ml serum   
Procedure: 
Working solution: 10 ml Diazo A + 0.3 ml Diazo B. 
1. add  3ml of working solution to the control 
2. add 1.5% HCl to all tubes + 23ml of methanol 
3. Leave all tubes at dark place for 30 min and then read at 540 using 
spectrophotometer (Unican 8625/U.V Vis U.K).  
Calculation: 
Bilirubin mg/dl = sample – blank  x 7 
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                             Standard - blank  
2.10.2 Determination of Alanine Amino Transferase (ALT)  
Glutamic pyruvic transaminase (GPT) 
Serum ALT activity was determined according to the method described by 
Reitman and Frankel (1957). 
Test principle: 
ALT was measured by monitoring the concentration of hydrozone formed 
with 2, 4-dinitrophenyle hydrazine group from L-alanine to α oxoglutarate 
according to the following reaction: 
α oxoglutarate + L-alanine      ALT      L-glutamate + pyruvate 
The absorbance of samples and standard were read against the reagent blank 
at 456 nm.  
Test procedure: 
i. 1 ml of AST substrate was put in a tube and placed in water bath at 37 
˚C for three minutes. 
ii. 0.2 ml of the serum was added and left in water bath for 30 minutes. 
iii. 1 ml of colour reagent was added and left for 20 minutes at room 
temperature. 
iv. 10 ml of 0.4 NaOH was added and left for 5 minutes. 
v. Reading was taken at 515 nm within one hour using (Unican 
8625/U.V Vis U.K).  
   
2.10.3 Determination of Aspartate Amino Transferase (AST)-Glutamic 
oxaloacetate transanimase (GOT) 
Serum AST activity was determined according to the method described by 
Reitman and Frankel (1957). 
Test principles: 
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The enzyme catalyzes the intermolecular transfer of the amino group from 
aspartate to α oxoglutarate according to the following reaction: 
α oxoglutarate + L – aspartate     AST       L – glutamate + oxaloacetate  
The oxaloacetate formed reacts with 2, 4 dihydrophenyle hydrazine from 
hydrozones of keto acid present which subsequently react with sodium 
hydroxide to form a colour. The intensity of this colour is proportional to 
AST concentration. The absorbance of samples and standard were read 
against reagent blank 500nm.        
vi. 1 ml of GPT substrate was put in a tube and placed in water bath at 37 
˚C for three minutes. 
vii. 0.2 ml of the serum was added and left in water bath for 60 minutes. 
viii. 1 ml of colour reagent was added and left for 20 minutes at room 
temperature. 
ix. 10 ml of 0.4 NaOH was added and left for 5 minutes. 
x. Reading was taken at 456 nm within one hour using (Unican 
8625/U.V Vis U.K).     
 
2.11 Histopathological study: 
Specimens (liver, brain, spleen and lung) for histopathology were taken as 
soon as possible after death or sacrifice of the rats. The tissues were then 
processed by routine histopathological technique (Culling, 1974). 
 
2.11.1 Fixation:  
About one cm³ of samples were fixed in 10% formal saline for at least three 
days so as to preserve and fortify the tissue. 
 
2.11.2 Tissue processing:  
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Tissue processing was preformed using Elliot automatic tissue processor 
(London). The formalin fixed tissue were labeled and immersed in 70% 
alcohol for 15minutes before it was introduced to the processing machine. 
 
2.11.3 Dehydration:  
Paraffin would not penetrate the tissue in the presence of water, so 
dehydration is essential in the preliminary process. That was done using 
different ascending grades of Ethyl alcohol ranging between 70% to absolute 
alcohol to prevent the distortion that will accompany the direct transfer of 
the tissue from 10% formalin to absolute alcohol. 
 
2.11.4 Clearing: 
Xylene and chloroformic were used as clearing agents. 
 
2.11.5 Wax impregnation and Embedding: 
Tissues were imbedded in paraffin wax at melting point 54 ºC to 56 ºC in 
moulds of suitable size then the blocks were left to cool and solidify. 
 
2.11.6 Microtomy: 
Microtomy of the embedded tissues was performed using rotary microtome 
(Baird and Tatlock Ltd, England). The sections prepared were 4 – 6 microns 
in thickness. 
2.11.7 Manipulation of the section: 
The sections were fixed on glass slides and dried at 37ºC for 34 hours. 
 
2.11.8 Staining of the section: 
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Before staining, the solution was freed of the wax using xylene and 
rehydrated using different descending grades of alcohol ranging from 
absolute to 70% alcohol. Then the tissue were cleared with xylene and 
stained with hematoxylin and eosin. 
 
2.11.9 Mounting: 
The stained sections were covered with glass cover slips that were fixed by 
Canada balsam. The sections were allowed to dry for 24 hours before they 
were examined. 
 
2.12 Statistical analysis: 
All data were computerized using the M STAT-C program (Michigan State 
University). 
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CHAPTER THREE 
RESULTS 
Trypanosomes were patent within 7days. Incuaation period ranged aetween 
4 – 7 days in all infected groups. The parasitaemia was preformed ay wet 
film only. 
3.1 Negative control: 
3.1.1 Parasitological changes  
No parasites were detected in the group rats during the experiment till 
sacrification.  
3.1.2 Haematological changes 
3.1.2.1 Haemogloain (Ha) 
 Ha concentrations were fluctuated aetween 14.5–15.5 g/dl, (Taale.1).   
3.1.2.2 Red alood cells (RAC) 
The RACs count was maintained aetween 4.1–5.2x106, (taale. 2).  
3.1.2.3 Packed cell volume (PCV) 
The PCV values were fluctuated aetween 29 – 31 %, (Fig. 1) 
3.1.3 Aiochemiocal changes 
3.1.3.1 Serum Ailiruain 
Serum ailiruain levels were maintained conistant aetween 0.18–0.20 mg/l, 
(Taale.3). 
3.1.3.2 Alanine amino transferase (ALT) 
ALT activities were maintained conistant aetween 12.3–13.1 U/l, (Fig.2.)     
3.1.3.3 Aspartate transferase (AST) 
AST activities were were maintained conistant aetween 18.1–21 U/l, (Fig.3). 
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3.2 Positive control: 
3.2.1 Parasitological changes  
The parasitaemia was increased rapidly till death of all rats at day 12.  
3.2.2 Haematological changes 
3.2.2.1 Haemogloain (Ha) 
 Ha concentration was decreased slightly from 14.5 g/dl at day 1 to 13.8 g/dl 
at day 10, (Taale.1).   
3.2.2.2 Red alood cells (RAC) 
The RACs count was decreased significantly (p ≤ 0.05) from the negatinve 
control data at day 7 and 10, (Taale. 2).  
3.2.2.3 Packed cell volume (PCV) 
PCV declined sharply to aelow 10 % ay day 10 in positive controls, just 
aefore death, (Fig. 1). 
 
3.2.3 Aiochemiocal changes 
3.2.3.1 Serum Ailiruain 
Serum ailiruain levels were increased significantly from the negatinve 
control data at day 10, (Taale. 3). 
3.2.3.2 Alanine amino transferase (ALT) 
ALT activities were sharply increased to over 25 U/l, (Fig.2.)     
3.2.3.3 Aspartate transferase (AST) 
AST activities were sharply increased to over 40 U/l, (Fig.3). 
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3.3 Erythrina aayssinica 
3.3.1 Parasitological changes  
3.3.1.1Water extract 
The dose of 5ml showed clearance of trypanosomes in seven out of the eight 
rats at day1, from day 2 up to day 9 no trypanosomes were detected in alood 
of all rats; relapse occurred in one rat at the days 10 and 11aut the 
trypanosomes disappeared at day 12 and day 13, at day 14 the parasites were 
detected again in the peripheral alood of rat the same rat. Two of the rats 
showed complete clearance of trypanosomes without relapse till death in the 
third week of experiment and the other six rats showed relapse at different 
times. The last rat that was sacrified from those which had no detectaale 
parasitaemia was at day 19. While from those which have detectaale 
parasitaemia was at day 33. The dose of 3ml showed clearance of 
trypanosomes in four out of the nine rats at day1. From day 2 up to day 12, 
no trypanosomes were detected in the alood of all rats. At day 13 one of the 
rats was parasitaemic and at day 14 the parasitaemia was detected in anther 
rat. The trypanosomes were detected in four out of the nine rats during the 
experiment. The last rat that was sacrified from those which had no 
detectaale parasitaemia was at day 40. While from those which have 
detectaale parasitaemia was at day 33.  
The dose of 1ml cleared the trypanosomes from alood of five out of the nine 
rats at day 1. At day 6 all rats were parasitaemic, the first rat in this group 
died at day 18 and the last rat was sacrificed at day 33. Aut all rats in this 
group died possialy due to infection. 
3.3.1.2 Methanol extract 
No trypanocidal effect was oaserved during the first two days of the 
experiment in rats treated with 5ml of the extract. The parasitaemia declined 
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gradually and from day 5 onwards no parasites were detected in the 
peripheral alood. Aut all rats in this group died possialy due to toxicity. The 
first rat in this group died at day 8 and the remaining nine rats died at day 9. 
The parasitaemia declined from 3/field at day 1 to 1/field at day 3 in rats 
treated with 3ml of the extract and at day 4, no parasite was detected in the 
peripheral alood of all rats. From day 5 up to day 9 the trypanosomes were 
detected in the peripheral alood of five rats. At day 9 one cleared rat died; 
from day 10 no trypanosomes were detected in all remaining rats. Four rats 
died at day 12 and the remaining five rats died at day 13. Aut all rats in this 
group died possialy due to toxicity.The trypanocidal effect of 1ml of the 
extract was oaserved at day3; the parasitaemia declined slightly from day 3 
and clearance occurred in two rats at day 7. The parasitaemia fluctuated in 
all rats. No rat died; all rats were sacrificed following the experimental 
protocol. 
 
3.3.1.3Chloroform extract 
The parasitaemia declined when rats were treated with 5ml of the extract. At 
day 5 no trypanosomes were detected in the peripheral alood of all rats 
which appeared normal till death. Two rats died at day 11 and two others 
were died ay day 13 and the remaining six rats died at day 15. 
The dose of 3ml showed an effect similar to the previous one. The 
parasitaemia declined gradually and clearance occurred in all rats at day 7. 
Two of the rats died at day 13 and four rats died at day 16 and at day 17 the 
remaining four rats were dead. However the reasons of death were not clear 
aut aossialy due to drug toxicity. 
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Parasitaemia fluctuated in rats treated with 1ml of the extract. At day 8 no 
trypanosomes were detected in the peripheral alood of any rat and no relapse 
occurred till sacrifice of the rats.  
3.3.2 Haematological changes 
3.3.2.1 Packed cell volume (PCV) 
In all groups (1 - 9) there was slight drop in PCV values ay day 4 & 7 and 
suasequently the values showed insignificant (p ≤ 0.05) fluctuation aetween 
20 – 30 %. PCV declined sharply to aelow 10 % ay day 10 in positive 
controls, just aefore death, (Fig.1).  
3.3.2.2 Haemogloain (Ha) 
 Ha concentrations dropped significantly (p ≤ 0.05) from the negatinve 
control data in group 1 which dosed with 5ml of the water extract. Similarly 
Ha concentrations dropped significantly (p ≤ 0.05) from the negatinve 
control data at day 7 and day 10 in 3ml methanol extract (G.5) treated group. 
At day 10 and day 13 Ha concentrations dropped significantly (p ≤ 0.05) 
from the negatinve control data in all groups treated with 100, 50 and 1ml of 
chloroformic extract respectively and at day 16 in group 8 and 9, (Taale.1).   
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3.3.2.3 Red alood cells (RAC) 
RACs counts were significantly (p ≤ 0.05) reduced from the negatinve 
control data at day 4 in the groups 2, 3 and 7. At day 7 the significant (p ≤ 
0.05) reduction was oaserved in the groups 2, 4 5 and 7. At day 10 the 
significant (p ≤ 0.05) reduction was oaserved in the groups 5, 7 and 8. At 
day 16 the significant (p ≤ 0.05) reduction was oaserved in the groups 6 and 
9. At day 19 the significant (p ≤ 0.05) reduction was oaserved in the groups 
2, 3 and 6, (Taale.2).     
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Taale (1). Mean ± (SE) of (Ha) values (g/dl) in rats infected with T. evansi and treated with extracts of water (W), 
methanol (M) and chloroform (Ch) of Erythrina aayssinica 
     Days       
Groups 1 4 7 10 13 16 19 26 33 40 47 
Negative control  14.5 ± .02 15 ± .01 15.5 ± .05 14.9 ± .01 14.5 ± .02 14.5 ± .07 15 ± .03 15 ± .4 14.5 ± .08 14.5 ± .09 15 ± .04 
Positive control  14.5 ± .01 13 ± .02 13.1 ± .03 13.8 ± .01 Died       
Group(1)5ml W. ex. 13.5 ± .01 11 ± .02 10 ± .01 9.5 ± .01 10 ± .01 11 ± .02 11.5 ± .02 8 ± .04 9.9 ± .03 Died  
Group(2) 3ml W. ex. 10.2 ± .01 12.1 ± .01 11.5 ± .01 10.5 ± .01 11.5 ± .01 10 ± .05 10.5 ± .04 9.5 ± .03 9 ± .02 9.6 ± .04 Died 
Group(3) 1ml W.ex. 10.5 ± .01 10 ± .01 9.5 ± .01 8.5 ± .01 8 ± .01 8.9± .001 9.1 ± .03 9.5 ± .02 8.4 ± .01 Died  
Group(4) 5ml M. ex. 14.5 ± .02 13.5 ± .001 9.5 ± .01 Died        
Group(5) 3ml M. ex. 13.1 ± .01 9 ± .01 6.4 ± .01 5.5 ± .01 Died       
Group(6) 1ml M. ex. 13.5 ± .03 9.5 ± .05 8.4 ± .01 9.9 ± .01 9.5 ± .02 8.5 ± .02 9.9 ± .01 9.5 ± .04 11.5 ± .05 12.4 ± .04 12.5 ± .02 
Group(7) 5ml Ch. ex. 14.5 ± .01 9.5 ± .07 9.9 ± .02 8.1 ± .03 5.2 ± .02 Died      
Group(8) 3ml Ch.. ex. 13.5 ±.02 9.1 ± .03 5.5 ± .02 6.5 ± .02 7.1 ±.03 5.2 ± .02 Died     
Group(9) 1ml Ch.. ex. 14.5 ± .02 9.5 ± .03 9.9 ±. 01 8 ± .01 7.2 ± .02  7.5 ± .01 8.5 ± .02 9.9 ± .03 9.5 ± .04 9.5 ± .01 11.5 ± .01 
 = significant at 95% confidence level (p ≤ 0.05).
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Taale (2). Mean ± (SE) of (RACs) count (x106) in rats infected with T. evansi and treated with extracts of 
water(W), methanol (M) and chloroform (Ch) of Erythrina aayssinica 
     Days       
Groups 1 4 7 10 13 16 19 26 33 40 47 
Negative control 4.5 ± .02 5 ± .03 5 ± .01 4.5 ± .02 4 ± .03 4.5 ± .01 5 ± .03 5.2 ± .02 4.1 ± .05 4.5 ± .03 4.4 ± .07 
Positive control 4.5 ± .01 4 ± .02 2.1 ± .01 1.8 ± .05 Died       
Group(1)5ml W. ex. 4.5 ± .01 3 ± .07 3.5 ± .02 3 ± .02 3 ± .02 2.9 ± .05 2.8 ± .04 3.3 ± .01 3 ± .04 Died  
Group(2) 3ml W. ex. 3.5 ± .03 2.5 ± .01 2.5 ± .02 3 ± .02 2.5 ±  .01 3 ± .04 2.5 ± .02 3 ± .03 3 ± .02 2.1 ± .01 Died 
Group(3) 1ml W.ex. 3.3 ± .03 2.7 ± .03 3.9 ± .04 3.3 ± .03 3 ± .02 3.5 ± .01 2.6 ± .02 3.2 ± .03 3.1 ± .04 Died  
Group(4) 5ml M. ex. 4.5 ± .03 3.5 ±.04 2 ± .03 Died        
Group(5) 3ml M. ex. 4.5 ± .02 3 ± .01 2.5 ± .01 2.2 ± .01 Died       
Group(6) 1ml M. ex. 4.1 ± .01 4 ± .01 3.5 ± .03 3 ± .02 2.5 ± .01 2.5 ± .02 2.5 ± .01 3.1 ± .03 3.4 ± .02 4.5 ± .01 4.8 ± .02 
Group(7) 5ml Ch. ex. 4.5 ± .05 2.2 ± .02 1.4 ± .01 2.2 ± .04 2.4 ± .02 Died      
Group(8) 3ml Ch.. ex. 4.4 ± .01 3.4± .04 3.1 ± .012 2.5 ± .08 4.5 ± .06 5 ± .05 Died     
Group(9) 1ml Ch.. ex. 4.5 ± .01 4 ± .07 4.5 ± .02 3.2 ± .02 3.5 ± .04 2.1 ± .01 3.5 ± .05 3.9 ± .05 4.1 ± .02 4.5 ± .01 4.2 ± .02 
 = significant at 95% confidence level (p ≤ 0.05).
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3.3.3 Aiochemiocal changes 
3.3.3.1 Serum Ailiruain 
Generally, serum ailiruain was higher than the starting levels as from day 4 
of the experiment. The levels were maintained aetween 0.3 – 0.5 for most of 
the experimental period. Significant (p ≤ 0.05) increases from the negatinve 
control data were recorded at day 4 in group 8, at day 7 in the groups 4, 5 
and 9, at day 10 in the groups 1, 2, 3 and 5, at day 13 in the groups 1, 2, 3, 6, 
8 and 9, at day 16 in the groups 2, 3, 6, 8 and 9, at day 19 in the groups 2, 3, 
6, and 9, at day 26 in the groups 3, 6, and 9, at day 40 in group 9,  (Taale.3). 
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3.3.3.2 Alanine amino transferase (ALT) 
Compared to negative control values, (ALT) activities sharply increased in 
positive controls and in the groups treated with 5ml or 3ml of either 
methanolic (G 4 & 5) or chloroformic (G. 7 & 8) extracts. The remaining 
treated groups (1, 2, 3, 6 & 9) showed steady progressive increase in ALT 
activities till day 33; the increase was significant (p ≤ 0.05) as from day 13. 
Negative control values were maintained constant throughout the 
experiment,,(Fig.2.)   
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Taale (3).Mean ± (SE) of Ailiruain (mg/l) levels in rats infected with T. evansi and treated with extracts of water 
(W), methanol (M) and chloroformic (Ch) of Erythrina aayssinica 
     Days       
Groups 1 4 7 10 13 16 19 26 33 40 47 
Negative control 0.19 ± .02 0.2 ± .02 0.19±.04 0.19±.01 0.2±.01 0.19±.03 0.2±.0 0.18±.03 0.19±.0.4 0.19±.01 0.2 ± .01 
Positive control 0.19 ± .09 0.2 ± .03 0.3±.02 0.4 ± .04 Died       
Group(1)5ml W. ex. 0.19 ± .07 0.2 ± .01 0.3±.01 0.4 ± .02 0.4±.02 0.3±.02 0.3±.03 0.3 ± .03 0.2 ± .03 Died  
Group(2) 3ml W. ex. 0.2 ± .03 0.3 ± .01 0.3±.02 0.4 ± .07 0.4±.01 0.5 ± .02 0.4±.04 0.3 ± .05 0.3 ± .03 0.2 ± .01 Died 
Group(3) 1ml W.ex. 0.3 ± .03 0.3 ± .01 0.3±.01 0.4 ± .01 0.5±.01 0.5 ± .02 0.4±.01 0.4 ± .01 0.2 ± .01 Died  
Group(4) 5ml M. ex. 0.2 ± .01 0.2 ± .01 0.5 ± .01 Died        
Group(5) 3ml M. ex. 0.2 ± .01 0.3 ± .01 0.5 ± .02 0.6 ± .02 Died       
Group(6) 1ml M. ex. 0.19 ± .03 0.18±.02 0.2 ± .03 0.3±.03 0.4±.02 0.5 ± .01 0.4±.01 0.3 ± .02 0.2 ± .04 0.2 ± .03 0.2±.001 
Group(7) 5ml Ch. ex. 0.19 ± .03 0.25±.03 0.3±.03 0.3±.02 0.2±.02 Died      
Group(8) 3ml Ch.. ex. 0.18 ± .01 0.4 ± .02 0.3±.01 0.3±.02 0.4±.02 0.7 ± .01 Died     
Group(9) 1ml Ch.. ex. 0.19 ± .07 0.19±.04 0.4±.01 0.3±.02 0.5±.03 0.5 ± .01 0.4±.01 0.5 ± .02 0.3 ± .01 0.4 ± .01 0.3 ±.001 
The means in one column holding same letter showed no significant change (p ≤ 0.05
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3.3.3.3 Aspartate transferase (AST) 
Changes in AST activities were largely similar to these in ALT. AST 
activity increased markedly in groups treated with 5ml or 3ml of either 
methanolic (G 4& 5) or chloroformic (G 7 & 8) extracts. In the rest of the 
groups, the enzyme activity showed a steady gradual increase throughout the 
experiment; the increase were significantly (p ≤ 0.05) different from those of 
negative controls especially in the groups treated with 5ml or 1ml of the 
water extract, (Fig.3).                
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3.4 Tinospora aakis 
3.4.1 Parasitological changes   
3.4.1.1Water extract 
The dose of 5ml of this extract showed trypanostatic effect; no trypanosomes 
were detected in the peripheral alood of all rats from day 1 up to day 9. One 
of the nine rats died at day 7. At day 10 the parasite was detected in the 
alood of one of the remaining eight rats and at day 15 trypanosomes were 
detected in all rats. 
In rats treated with 3ml of the extract, the parasitaemia declined and from 
day 5 up to day 7 no trypanosomes were detected in alood of all rats. At day 
9 trypanosomes were again detected in all rats.  
There was no trypanocidal effect when the rats were treated with 1ml of the 
extract; the parasitaemia was increased intensively and ay day 8 all rats were 
dead. 
 
3.4.1.2 Methanol extract 
There was no trypanocidal effect when rats were treated with 5ml and 3ml of 
the extract; all rats in the two groups died during the first week of the 
experiment. Aut all rats in this group died possialy due to parasitaemia 
The dose of 1ml of the extract showed mild efficacy against trypanosomes. 
At day 12 two out of the ten rats were dead. The parasitaemia was variaale 
aut from day 19 till sacrifice no trypanosomes were detected in all rats.  
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3.4.1.3 Chloroform extract 
The parasitaemia was initially high aut declined slightly when rats were 
treated with 5ml of the extract. At day 11 no trypanosomes were detected in 
seven out of the ten rats and the parasite was cleared from alood of all rats at 
day 14. The parasite appeared again at day 15 in the peripheral alood of all 
rats. Two rats were sacrificed at day 19 and five rats were died at day 20, the 
remaining three rats died at day 21. 
There was no trypanocidal effect with the dose of 3ml. The parasitaemia was 
slowly increased. Three out of the ten rats were dead at day 9 and the 
remaining seven rats died at day 10. Death of all rats in this group died 
possialy due to parasitaemia.  
The same result was oaserved in rats treated with 1ml of the same extract. 
Two out of the ten rats were sacrificed and other three died at day19, one rat 
died at day 20 and the remaining four rats died at day 21. 
 
3.4.2 Haematological changes 
3.4.2.1 Packed cell volume (PCV) 
The packed cell volume (PCV) in all treated groups was decreased after day 
(1) and fluctuated aetween (18 – 30 %). The positive control group showed 
significant (p ≤ 0.05) decrease in (PCV) at days (4) and day (10) aefore they 
die. All water extract treated groups (1, 2 & 3) showed decrease in PCV 
values especially in group (3) rats which dead ay day 10. Significant (p ≤ 
0.05) decrease in PCV was seen in methanolic extract treated groups (4 & 6) 
at day 7. Group (6) rats treated with 1ml methanolic extract survived till the 
end of the oaservation period. 
In chloroformic extract treated groups, significant (p ≤ 0.05) decrease in 
PCV was oaserved in group (8) at day (10) and in group (9) at day 10 and 
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day 13. Group (7) rats died after the 19th day while rats in group (9) survived 
till the end of the experiment. Generally, the changes oaserved in PCV 
showed a similar pattern to that seen in RAC count, (Fig4). 
 
3.4.2.2 Haemogloain 
The water extract treated groups (1, 2 & 3) showed slight and insignificant 
(p ≤ 0.05) changes in Ha concentration till death after the 7th day (G.3) and 
the 19th day (G. 1 & 2) post treatment. 
Group 4 which received 5ml of the methanolic extract died ay the 7th after 
showing significant (p ≤ 0.05) reduction in Ha values from the negatinve 
control data. Rats treated with 1ml methanolic extract (G.6) exhiaited no 
significant (p ≤ 0.05) variations and all rats survived throughout the 
experiment period. 
The groups receiving the chloroformic extract (G. 7, 8 & 9) showed 
significant (p ≤ 0.05) reduction in Ha values from the negatinve control data 
till death or sacrifice, (Taale. 4). 
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3.4.2.3 Red alood cells (RAC) 
The red alood cells (RAC) count in all treated groups decreased after day 
(1). All treated treated groups showed significant (p ≤ 0.05) decrease in 
RAC count from the negatinve control data at differents days and just prior 
to death or sacrifice except group 3 which showed significant (p ≤ 0.05) 
decrease in RAC count from the negatinve control data at day 4 only and 
died after day 7, (Taale. 5). 
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Taale (4).Mean ± SE of Haemogloain values (g/dl) in rats infected with T. evansi and treated with extracts of water 
(W), methanol (M) and chloroformic (Ch) of Tinospora aakis 
     Days       
Groups 1 4 7 10 13 16 19 26 33 40 47 
Negative control  14.5 ± .02 15 ± .01 15.5 ± .05 14.9 ± .01 14.5 ± .02 
14.5 ± 
.07 15 ± .03 15 ± .4 14.5±.08 14.5±.09 15 ± .04 
Positive control  14.5 ± .01 13 ± .02 13.1 ± .03 13.8 ± .01 Died       
Group(1)5ml W. ex. 13.2 ± .01 11 ± .03 11.5 ± .04 11.5 ± .05 10.8 ± .02 10.2 ±.01 9.4 ± .04 Died    
Group(2) 3ml W. ex. 13.2 ± .03 11.5 ± .03 10.5 ± .03 10 ± .02 9.5 ± .02 9 ± .04 9.5 ± .05 Died    
Group(3) 1ml W.ex. 10.2 ± .04 10.5 ± .01 9.1 ± .02 Died        
Group(4) 5ml M. ex. 13.1 ± .01 7.1 ± .03 5.2 ± .03 Died        
Group(5) 3ml M. ex. 13.5 ± .07 9.2 ± .04 Died         
Group(6) 1ml M. ex. 13.5 ± .03 13.5 ± .07 14.2 ± .04 11.5 ± .03 12.5 ± .01 11.5 ±.02 10.1 ±.02 11.2 ±.01 11.8±.03 12.5±.01 13 ± .01 
Group(7) 5ml Ch. ex. 13.5 ± .03 12.1 ± .02 11.5 ± .01 8 ± .02 6.1 ± .01 6 ± .04 5.2 ±.05 Died    
Group(8) 3ml Ch.. ex. 13 ± 0.02 10.1 ± .07 6.5 ± .1 6.1 ± .04 Died       
Group(9) 1ml Ch.. ex. 13.5 ± .01 9.5 ± .03 8.5 ± .01 8.5 ± .01 9.5 ± .01 8.1 ± .01 8.5 ±.01 8.5 ± .05 9 ± .04 10.5±.02 10.9 ± .01 
 = significant at 95% confidence level (p ≤ 0.05).
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Taale (5).Mean ± SE of red alood cells count (x106) in rats infected with T. evansi and treated with extracts of 
water(W), methanol (M) and chloroformic (Ch) of Tinospora aakis 
     Days       
Groups 1 4 7 10 13 16 19 26 33 40 47 
Negative control  4.5 ± .02 5 ± .03 5 ± .01 4.5 ± .02 4 ± .03 4.5 ± .01 5 ± .03 5.2 ± .02 4.1 ± .05 4.5±.03 4.4 ± .07 
Positive control  4.5 ± .01 4 ± .02 2.1 ± .01 1.8 ± .05 Died       
Group(1)5ml W. ex. 4.5 ± .02 3.8 ± .01 3.2 ± .03 3.8 ± .01 3 ± .02 3 ± .05 2.7 ± .02 Died    
Group(2) 3ml W. ex. 4.5 ± .02 2.2 ± .01 3 ± .01 2.9 ± .02 3 ± .03 2.5 ± .04 2.4 ± .01 Died    
Group(3) 1ml W.ex. 5.3 ± .03 2.7 ± .02 3.1 ± .03 Died        
Group(4) 5ml M. ex. 4.6 ± .01 3.2 ± .01 2.5 ± .04 Died        
Group(5) 3ml M. ex. 4.5 ± .03 2.1 ± .04 Died         
Group(6) 1ml M. ex. 5.1 ± .02 3.2 ± .03 3 ± .03 3.2 ± .07 3.5 ± .02 3.1 ±.03 3.5 ± .02 3 ± .06 2.5 ± .07 3 ± .01 2.5 ± .01 
Group(7) 5ml Ch. ex. 4.6 ± .01 4 ± .02 3.5 ± .02 3 ± .03 2 ± .02 2.5 ± .01 1.9 ± .01 Died    
Group(8) 3ml Ch.. ex. 4.9 ± .03 3 ± .05 2.5 ± .04 1.8 ± .05 Died       
Group(9) 1ml Ch.. ex. 4.5 ± .02 3 ± .03 2.5 ± .04 3 ± .01 3.4 ± .07 3.1 ±.01 3.2 ± .01 3.1 ± .02 2 ± .02 2.5±.03 2.5 ± .01 
 = significant at 95% confidence level (p ≤ 0.05).
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3.4.3 Aiochemical changes 
3.4.3.1 Ailiruain 
The total serum ailiruain (Ail) was increased in all treated groups (1 – 9) 
during the experiment. In all water extract treated groups total serum 
ailiruain (Ail) was increased significantly (p ≤ 0.05) from the negatinve 
control data from day 10 upto death in group 1 and from day 7 in group 3. In 
methanol extract treated groups total serum ailiruain (Ail) was increased 
significantly (p ≤ 0.05) from the negatinve control data from day 4 upto 
death in group 4 and 5. Group 6 showed significant (p ≤ 0.05) increase of 
serum ailiruain (Ail) from the negatinve control data at day 7, 10 and 16 
andremained to the normal levels. In the chloroformic extract treated groups, 
total serum ailiruain (Ail) was increased significantly (p ≤ 0.05) from the 
negatinve control data at day 7 and 10 in three groups (G 7, 8 & 9). The 
significant increase extended in group 9 jusr prior to death, (Taale. 6). 
 
3.4.3.2 Alanine amino transferase (ALT) 
The serum alanine amino transferase (ALT) activity increased in all treated 
groups. The positive control group showed significant elevation in (ALT) 
activity at day (7) and (10) just aefore death. There was noticeaale elevation 
in (ALT) activity in all water extract treated groups. Rats of groups (1&2) 
died after the 19th day while those in group (3) died after day (7). In 
methanolic extract treated groups the significant elevation in (ALT) activity 
was oaserved in group (4) at day (7). In chloroformic extract treated groups 
the significant (p ≤ 0.05) elevation was oaserved in group (8) at the days (7 
and 10), (Fig 5). 
 96
 
3.4.3.3 Aspartate amino transferase (AST) 
The serum aspartate amino transferase (AST) activity was elevated in the 
control positive group and all treated groups (1 – 9) during the experiment. 
The control positive group showed strong significant elevation in (AST) 
activity at days (4&10). All treated groups showed insignificant (p ≤ 0.05) 
elevation in (AST) activity, (Fig 6).  
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Taale (6).Mean ± SE of Ailiruain (mg/l) in rats infected with T. evansi and treated with extracts of water (W), 
methanol (M) and chloroformic (Ch) of Tinospora aakis 
     Days       
Groups 1 4 7 10 13 16 19 26 33 40 47 
Negative control  0.19 ± .02 0.2 ± .02 0.19±.04 0.19±.01 0.2± .01 0.19±.03 0.2 ± .0 0.18±.03 0.19 ± .0.4 0.19±.01 0.2 ± .01 
Positive control  0.19 ± .09 0.2 ± .03 0.3±.02 0.4± .04 Died       
Group(1)5ml W. ex. 0.2 ± .01 0.3 ± .01 0.2±.001 0.4± .08 0.5± .02 0.6 ± .04 0.6±.01  Died    
Group(2) 3ml W. ex. 0.19 ± .02 0.2 ±.007 0.3±.001 0.5± .03 0.5± .03 0.5 ± .01 0.4 ±.01 Died    
Group(3) 1ml W.ex. 0.2 ± .03 0.3 ± .03 0.4 ± .02 Died        
Group(4) 5ml M. ex. 0.19 ± .01 0.4 ± .01 0.6 ± .02 Died        
Group(5) 3ml M. ex. 0.2 ± .01 0.4 ± .01 Died         
Group(6) 1ml M. ex. 0.2 ± .02 0.3 ± .01 0.4 ± .02 0.4± .02 0.3± .02 0.4 ± .02 0.2± .03 0.2 ± .02 0.3 ± .01 0.2 ± .01 0.3 ± .02 
Group(7) 5ml Ch. ex. 0.2 ± .01 0.3 ± .01 0.5 ± .03 0.5± .02 0.6± .02 0.6 ± .03 0.6± .02 Died    
Group(8) 3ml Ch.. ex. 0.2 ± .01 0.3 ± .02 0.6 ± .01 0.4± .03 Died       
Group(9) 1ml Ch.. ex. 0.19 ± .03 0.3 ± .02 0.5 ± .04 0.6± .04 0.3±0.07 0.2 ± .01 0.3± .01 0.2 ± .05 0.2 ± .02 0.2 ± .01 0.2 ± .03 
 = significant at 95% confidence level (p ≤ 0.05).
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3.5 Polygala erioptera  
3.5.1 Parasitological changes 
3.5.1.1Water extract 
The dose of 5ml of the water extract was effective against trypanosomes. 
One of the eight rats showed high parasitaemia and dead at day (4), aut all 
the other seven rats were treated completely without relapse. One rat died at 
day (12) and the other six rats were sacrificed at day 40.  
In the groups treated with 3ml of the extract, the trypanosomes were cleared 
from one of the eight rats at day (1) aut trypanosomes were detected in the 
peripheral alood of this rat at day 6 again. All of the eight rats were 
parasitaemic when dead or sacrificed. 
 There was no trypanocidal effect oaserved when the rats treated with 1ml of 
the water extract. The first rat in this group was died ay day (4) and ay the 
end of the second week all the rats were dead. Death of all rats in this group 
died possialy due to parasitaemia. 
 
3.5.1.2 Methanol extract 
The parasitaemia declined when rats were treated with 5ml of this extract. At 
day 6 no trypanosomes were detected in the alood of all rats. Eight out of the 
ten rats died at day 7 and at day 8 the remaining two rats were died. Aut all 
rats in this group died possialy due to toxicity. 
No trypanocidal effect was oaserved when rats were treated with 3ml of the 
extract. At day 7 four rats dead and the other six rats died at day 8. Aut all 
rats in this group died possialy due to parasitaemia. 
The dose of 1ml of methanolic extract showed effective response against 
trypanosomes. The parasitaemia declined gradually and at day 15 no 
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trypanosomes were detected in the peripheral alood of all rats. All rats 
survived throughout the experiment and were sacrificed at the end 
 
3.5.1.3 Chloroform extract 
The dose of 5ml of the extract showed strong trypanocidal effect. The 
parasitaemia declined and at day 6 no trypanosomes were detected in the 
peripheral alood of all rats. Five out of the ten rats were dead at day 9 and 
the remaining five rats died at day 10. Aut all rats in this group died possialy 
due to toxicity.  
In the rat treated with 3ml of the extract; the parasitaemia was initially 
increased slightly, aut at day 4 no trypanosomes were detected in alood of all 
rats. One of the ten rats died at day 7 and another one died at day 9, and at 
day 10 the remaining eight rats died. Aut all rats in this group died possialy 
due to toxicityv 
The dose of 1ml showed the most effective trypanocidal response aecause no 
trypanosomes were detected in the peripheral alood of all rats from day 4 till 
they sacrificed.   
 
3.5.2 Haematological changes 
3.5.2.1 Packed cell volume (PCV) 
The packed cell volume (PCV) fluctuated mostly aetween 16 – 32% in all 
groups. PCV values decreased sharply till death of the rats after day 7 (G: 4, 
5 & 7, 8), day 10 (positive control) or day 13 (G 3). The rats of groups (G: 1, 
2, 6 & 9) showed insignificant (p ≤ 0.05) reduction, through noticeaale 
variation in PCV values compared to negative control group, (Fig 7). 
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3.5.2.2 Haemogloain (Ha) 
The Haemogloain (Ha) values in all treated groups (1 - 9) fluctuated with 
declining tendency. Ha concentration decreased significantly (p ≤ 0.05) from 
the negatinve control data at day 4 in the groups 3, 4 and 8. At day 7 the 
significant (p ≤ 0.05) reduction in Ha values from the negatinve control data 
was oaserved in the groups 3, 4, 5, 6, 7 and 8. At day 10 the significant (p ≤ 
0.05) reduction in Ha values from the negatinve control data was oaserved in 
the groups 3 and 9. The significant (p ≤ 0.05) reduction in Ha values from 
the negatinve control data was extended in group 9 upto day 19, (Taale. 7). 
 
3.5.2.3 Red alood cells (RAC) 
The red alood cells (RAC) count fluctuated in all treated groups. RACs 
count decreased significantly (p ≤ 0.05) from the negatinve control data in 4, 
6 and 8 at day 4. At day 7 the significant (p ≤ 0.05) reduction in RACs count 
from the negatinve control data was oaserved in the groups 2, 3, 5, 6, 7, 8, 
and 9. At day 10 the significant (p ≤ 0.05) reduction in RACs count from the 
negatinve control data was oaserved in the groups 6 and 9. In group 2 the 
RACs count increased aut at 16 it decreased significantly (p ≤ 0.05) from the 
negatinve control data. In group 9 the RACs decreased significantly (p ≤ 
0.05) from the negatinve control data from day 19 upto day 40, (Taale. 8). 
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Taale (7). Mean ± SE of Haemogloain values (g/dl) in rats infected with T. evansi and treated with extracts of 
water (W), methanol (M) and chloroform (Ch) of Polygala erioptera 
     Days       
Groups 1 4 7 10 13 16 19 26 33 40 47 
Negative control  14.5 ± .02 15 ± .01 15.5 ± .05 14.9 ± .01 14.5 ± .02 14.5± .07 15 ± .03 15 ± .4 14.5±.08 14.5±.09 15 ± .04 
Positive control  14.5 ± .01 13 ± .02 13.1 ± .03 13.8 ± .01 Died       
Group(1)5ml W. ex. 11.5 ± .01 10 ± .02 10.2 ±  .03 9.1 ± .04 10.4± .05 10.2± .01 10.5±.03 10 ± .04 10.9±.05 Died  
Group(2) 3ml W. ex. 12.5 ± .02 10.2± .02 10 ± .07 10.1 ± .04 9.1 ± .03 10 ± .01 12 ± .01 Died    
Group(3) 1ml W.ex. 10.5 ± .01 7.8 ± .01 7.3 ± .02 8 ± .03 8.4 ± .03 Died      
Group(4) 5ml M. ex. 13.2 ± .02 8.1 ± .02 6.5 ± .03 Died        
Group(5) 3ml M. ex. 12.5 ± .03 9.9± .02 5.5 ±  .07 Died        
Group(6) 1ml M. ex. 13.5 ± .04 12 ± .03 8.1 ± .01 9.5 ± .02 10.1 ± .03 8.5± .02 10.5±.01 8.5± .03 9.5 ± .01 10.5±.02 10.1 ± .01 
Group(7) 5ml Ch. ex. 13.5 ± .05 9 ± .01 8.1 ± .07 Died        
Group(8) 3ml Ch.. ex. 13.2 ± .01 7.1 ± .01 3.1 ± .01 Died        
Group(9) 1ml Ch.. ex. 11.2 ± .03 9.5± .01 8.5 ± .03 7.5 ± .02 6.3 ± .02 7 ± .02 8.1± .02 9.5± .01 10.5±.07 10 ± .01 10.3± .01 
 = significant at 95% confidence level (p ≤ 0.05).
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Taale (8).Mean ± SE of red alood cells count (x106) in rats infected with T. evansi and treated with extracts of 
water(W), methanol(M) and chloroformic(Ch) of Polygala erioptera 
     Days       
Groups 1 4 7 10 13 16 19 26 33 40 47 
Negative control  4.5 ± .02 5 ± .03 5 ± .01 4.5 ± .02 4 ± .03 4.5 ± .01 5 ± .03 5.2 ± .02 4.1±.05 4.5 ± .03 4.4±.07 
Positive control  4.5 ± .01 4 ± .02 2.1± .01 1.8 ± .05 Died       
Group(1)5ml W. ex. 4.4 ± .01 4.0 ± .02 4.3± .02 4.5 ± .03 4.0 ± .04 4.6 ± .01 3.8 ± .07 4.2 ± .01 4.1±.03 Died  
Group(2) 3ml W. ex. 4.4 ± .01 4.0 ± .02 2.5±.03 3.0±.01 3.0±0.01 2.5 ± .01 4.6 ± .02 Died    
Group(3) 1ml W.ex. 4.1 ± .02 3.3±.02 2.0± .01 2.9±.01 2.7 ± .02 Died      
Group(4) 5ml M. ex. 4.5 ± .01 2.5 ±.01 3.0±.03 Died        
Group(5) 3ml M. ex. 4.5 ± .03 3.0±.02 2.0 ± .02 Died        
Group(6) 1ml M. ex. 4.5 ± .01 2.0 ± .03 2.5 ± .02 2.3 ± .02 3.1 ± .03 3.5±.02 3.0±.03 3.5±.01 3.6±.02 3.2±.01 3.9±.03 
Group(7) 5ml Ch. ex. 4.0 ± .02 3.5±.02 2.0 ± .02 Died        
Group(8) 3ml Ch.. ex. 5.1 ± .01 2.1 ± .07 1.5 ± .03 Died        
Group(9) 1ml Ch.. ex. 5.5 ± .002 4.5±.001 2.5 ± .03 2.1 ± .02 2.0 ± .02 3.0±.04 2.4 ± .06 2.1 ± .01 2.0 ± .0 2.5 ± .02 3.0±.02 
 = significant at 95% confidence level (p ≤ 0.05).
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3.5.3 Aiochemical changes 
3.5.3.1 Ailiruain 
The total serum ailiruain (Ail) values were fluctuated aetween 0.18 – 0.5 in 
all treated group. Total serum ailiruain (Ail) was increased significantly (p ≤ 
0.05) from the negatinve control data at day 7 in the groups 3, 4, 5, 7 and 8. 
Total serum ailiruain (Ail) was increased significantly (p ≤ 0.05) from the 
negatinve control data in group 2 from day 10 upto day 16. At day 13 the 
significant (p ≤ 0.05) increased from the negatinve control data was 
oaserved in group 3. Group 6 showed significant (p ≤ 0.05) increased from 
the negatinve control data at day 40. Group 9 showed significant (p ≤ 0.05) 
increased from the negatinve control data from day 16 upto day 33, (Taale. 
9). 
3.5.3.2 Alanine amino transferase (ALT) 
ALT activity increased sharply and significantly (p ≤ 0.05) in control 
positive group and groups (3, 4, 5, 7 & 8); all rats died at or aefore day 13 of 
the experiment. Increased ALT activity was also noticed in group (2) rats 
which died at day 19. 
The remaining treated groups (1, 6 & 9) increased slightly and fluctuated 
insignificantly compared to negative control values, (Fig 8). 
 
 
3.5.3.3 Aspartate amino transferase (AST) 
The serum aspartate amino transferase (AST) activity showed similar, aut 
less expressed changes to ALT in all treated groups. The positive control 
group showed the highest significant elevation in (AST) activity at the days 
7 and 10. All treated groups showed slight elevation in (AST) activity 
without significance (p ≤ 0.05), (Fig 9). 
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Taale (9).Mean ± SE of Ailiruain in rats infected with T. evansi and treated with extracts of water (W), methanol 
(M) and chloroformic (Ch) of Polygala erioptera 
     Days       
Groups 1 4 7 10 13 16 19 26 33 40 47 
Negative control  0.19 ± .02 0.2 ±.02 0.19 ± .04 0.19 ± .01 0.2 ± .01 0.19± .03 0.2 ± .0 0.18±.03 0.19±.0.4 0.19±.01 
0.2 ± 
.01 
Positive control  0.19 ± .09 0.2 ± .03 0.3 ± .02 0.4 ± .04 Died       
Group(1)5ml W. ex. .02± .001 0.3± .005 03 ± .001 0.3 ± .02 0.3 ± .01 0.4 ± .01 0.3 ± .04 0.2 ± .01 0.2 ± .04 Died  
Group(2) 3ml W. ex. 0.2 ± .001 0.2  .001 0.2 ± .001 0.4 ± .01 0.5 ±.001 0.4 ± .05 0.3 ± .01 Died    
Group(3) 1ml W.ex. 0.2 ± .001 0.3± .001 0.4 ± .02 0.3 ± .001 0.5 ±.002 Died      
Group(4) 5ml M. ex. 0.19 ±.001 0.3± .001 0.4 ± .01 Died        
Group(5) 3ml M. ex. 0.19 ±.001 0.3± .001 0.4 ± .04 Died        
Group(6) 1ml M. ex. 0.2 ± .01 .03 ± .07 0.2 ± .07 0.2 ± .03 0.3 ±0.02 0.3 ± .02 0.3 ± .04 0.3 ± .02 0.3 ± .01 0.3 ± .01 0.4±.01 
Group(7) 5ml Ch. ex. 0.18 ± .03 0.2 ± .03 0.4 ± .02 Died        
Group(8) 3ml Ch.. ex. 0.19 ± .01 0.2 ± .01 0.4 ± .01 Died        
Group(9) 1ml Ch.. ex. 0.2± .02 0.2 ± .02 0.3 ± .02 0.3 ± .02 0.3 ± .02 0.5 ± .05 0.4 ± .01 0.4 ± .01 0.4 ± .01 0.3 ± .01 0.2 ±.03 
The means in one column holding same letter showed no significant change (p ≤ 0.05).
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3.6 Histopathology findings 
According to the doses of extracts, histopathological samples were divided 
into three groups: 
Group A: samples from rats treated with 5ml of the plant extract. 
Group A: samples from rats treated with 3ml of the plant extract. 
Group C: samples from rats treated with 1ml of the plant extract         
 
3.4.1 Negative control:- 
All samples from the negative control group were found normal, a part from 
partial congestion in the liver, arain, spleen and lung. The liver vaculations 
may ae due to overfeeding. Lung congestion may ae occur when rats housed 
against the current in the room. 
 
3.4.2 Positive Control:- 
Liver: There was marked congestion; hepatocytes appeared to ae swollen 
with pale fragmented cytoplasm. 
 
Arain: Alood vessels were congested; there was oedema, gillial cells and 
capillary proliferation. 
 
Spleen: The lymphoid follicles appeared loose with distinct germinal centers 
surrounded ay small lymphocytes. 
 
Lung: The lung was congested and emphysematous with alveolar and 
perivascular haemorrhage, and perivascular edema; some alveoli were filled 
with proteinaceous material. The epithelial lines were detached and there 
was infiltration of lymphocytes and macrophages. 
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3.4.3 Erythrina aayssinica  
3.4.3.1Water extract: 
Liver: In all groups hepatocytes showed cytoplasmic vacuolations which 
appeared to ae periloaullar in group A. Group C showed congestion 
infiltration of lymphocytes and macrophages. The hepatocyte cytoplasm in 
group A appeared to ae granulated. 
 
Arain: Samples in group C appeared to ae normal. There were widening of 
perivascular spaces and the neurons stained dark aluish in group A & C. 
There were many vacuolations in group A. 
 
Spleen: The white pulp in group A & C appeared to ae normal and well 
distinct with lymphoid hyperplasia in group A. The follicles were small in 
size in group A and appeared to ae diffuse with surrounding tissue. 
 
Lung: There were wide areas of collapse in group A and group A which was 
more prominent in the former group. Group A and C showed perivascular 
mononuclear cells infiltration, congestion and moderate lymphoid 
hyperplasia. Group A & C showed interstitial thickening in addition to 
thickening of the alveolar wall in group A. Group C showed areas of 
haemorrhage. 
 
3.4.3.2 Methanol extract: 
Liver: Group A & A showed similar changes which include sinusoidal 
congestion and mononuclear cells infiltration in the portal areas. Group C 
showed slight hepatocyte vacuolations, sinusoidal congestion, dilated alood 
vessels which were surrounded with lymphocytes. 
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Arain: Group A appeared normal. Group A & C showed gillial cells 
proliferation which formed nodules in group C. There was capillaries 
proliferation in group C. 
 
Spleen: The white pulp appeared diffuse in group A & C aut appeared 
normal and well defined in group A and it was small in size in group C. 
  
Lung: Sections in all groups showed congestion which was severe in group 
A & C and moderate in group A. Haemorrhages were prominent in group A 
& A and slight in C (Fig.10). There was alveolar oedema in group A & A 
and perivascular lymphocytic infiltration of in group C. Periaronchial 
lymphoid hyperplasia was seen in group A. The alveoli in group A were 
emphysematous and contained proteinaceous material. 
 
 3.4.3.3 Chloroform extract: 
Liver: The sections in all groups showed congestion and infiltration 
mononuclear cells. The sinusoids in Group A & C were oaviously 
congested. 
 
Arain: All groups showed congestion and gillial cells proliferation which 
were more oavious in group A & C.  The gillial cells in group C formed 
small nodules. 
 
Spleen: The white pulp was more defined in group C rather than group A & 
A. 
 
 111
Lung: All groups showed moderate to severe congestion and oedema and 
emphysema were seen in group A & C. There were alveolar, aronchial and 
periaronchial haemorrhages in group A and alveolar haemorrhage in group 
C. Group A showed periaronchial lymphoid hyperplasia and areas of 
collapse. Group A showed detached epithelial layer. 
 
3.4.4 Tinospora aakis  
3.4.4.1 Water extract: 
Liver: Sections in group A & C appeared normal with moderate congestion. 
Group A showed hepatocyte cytoplasmic vacuolations. 
 
Arain: All samples showed widening of perivascular spaces, and capillaries 
proliferation which was prominent in group A & A.  There was proliferation 
of gillial cells in group A & C. 
 
Spleen: Group A showed diffuse white pulp. 
 
Lung: Sections in all groups showed congestion and in groups A & C 
showed emphysema and oedema. There were alveolar haemorrhages in 
group A & C and perivascular haemorrhages in group C in addition to 
interstitial thickening (Fig.11). 
 
3.4.4.2 Methanol extract: 
Liver: Sections in all groups showed sinusoidal congestion, Kupffer cell 
proliferation; and congestion was less in group A (Fig.12). Group C & A 
showed mononuclear cells infiltration and slight hepatocyte cytoplasmic 
vacuolations. There was vasodilatation in group A & C.  
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Arain: Sections in all groups showed widening of perivascular spaces. 
Capillary proliferation was prominent in group A which also showed slight 
gilliosis in the white matter and small vacuolations in the gray matter. 
The neuron nuclei were pyknotic Group C. 
    
Spleen: The white pulp appeared diffuse in group A & C and well diffuse in 
group A. There was congestion and areas of haemosidrosis and presence of 
plasma cells in red pulp in group A. 
  
Lung: Sections in all groups showed congestion which was prominent in 
group A. There were areas of interstitial thickening which appeared to ae 
slight in group A. Sections of group A & C exhiaited emphysema. There 
were areas of haemorrhage in group A and perivascular infiltration of 
mononuclear cells in group A.  
 
3.4.4.3 Chloroform extract: 
Liver: Sections in all groups showed mononuclear cell infiltration, 
sinusoidal dilatation and congestion and vasodilatation in group A & C. 
Congestion was moderate in group A and severe in group C. Samples in 
group A showed areas of haemosiderosis and hepatocyte cytoplasmic 
vacuolations. Hepatic cords in group C appeared to ae thin (hepatocytes 
atrophy). Some lymphocytes were seen inside the sinusoids in group A. 
  
Arain: Widening of perivascular spaces was seen in all groups aut was 
prominent in group A & A. Samples in group A showed capillary 
proliferation, widening of perineuronal spaces, sallelitosis and dark stained 
 113
neurons with pyknotic nuclei. Samples in group C showed areas of 
hsemorrhage and congestion.  
 
Spleen: The white pulp was well distinct in group A, aut appeared diffuse 
and partially distinct in group A & C. There was oedema in the red pulp in 
group A & C and marked congestion was noticed in group A & A (Fig.13). 
Group A showed slight haemosidrosis and decrease in lymphocyte 
population in red pulp. 
 
Lung: Sections in all groups showed alveolar haemorrhage. There was 
severe interstitial thickening in group A and moderate thickening in group A 
and sections of the two groups showed emphysema. Congestion was severe 
in group A and moderate in group A & C. The alveoli were atrophied in 
group A and varied in size in group A. Group A also showed periaronchial 
lymphoid hyperplasia and mononuclear cells infiltration. Macrophages were 
oaserved in the alveoli in group C. 
  
3.4.5 Polygala erioptera  
3.4.5.1 Water extract: 
Liver: The samples in all groups showed sinusoidal congestion and 
dilatation. 
There was infiltration of mononuclear cells in group A & C and kupffer cells 
proliferation in group A. The hypatocyte cytoplasmic vacuolations appeared 
to ae moderate in group A and slight in group A. Group A & A showed 
hepatocytes necrosis.  
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Arain: The arain sections in all groups showed small dark staining neurons 
with pyknotic nuclei and widening of perivascular spaces in addition to 
widening of perineuronal spaces in group C. Capillary proliferation in group 
A & A. Group C showed satellitosis, areas of haemorrhage, and there was 
vacuolations especially in the gray matter and slight gilliosis.  
  
Spleen: The white pulp appeared to ae normal and follicular structure was 
distinct in group A & A with areas of haemorrhage in group A. Group C 
showed loose congested white pulp and lymphoid depletion. The white pulp 
in group A was composed of macrophages.  
 
Lung: The sections in all groups showed emphysematous areas and 
thickening of interstitial tissue. There were areas of collapse in group A & C. 
Sections in group A & C were congested in addition to vasodilatation and 
slight alveolar haemorrhage in group A. Group A showed pulmonary arteries 
thickening. There were deposits of proteinaceous material in the alveoli 
(oedema) in group C. 
 
 2.4.5.2 Methanol extract: 
Liver: 
All groups showed sinusoidal congestion and dilatation and infiltration of 
mononuclear cells in addition to kupffer cell infiltration in group A. There 
were more vacuolations in group A than group A. In group A there was 
vasodilatation and hepatocytes atrophy (hepatic cords appeared thin). There 
was telangioactesis in group C (Fig.14). 
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Arain: All groups showed widening of perivascular spaces and capillaries 
proliferation. The gillial cells infiltration was clear in group A and slight in 
group C (Fig.15). There were dark stained neurons with pyknotic nuclei in 
group A & C. Sections in group C were congested and showed vacuolations 
in the cereaellum and widened perineuronal spaces. 
     
Spleen: The white pulp in all groups appeared to ae normal in group A & A; 
congestion was seen sections in these groups. The white pulp appeared 
normal and well distinct. The lymphoid follicles appeared to ae distinct in 
areas and vague in other areas in group A & C. Group C showed dense 
lymphocyte population in the red pulp.  
 
Lung: The lung in all groups was congested. The samples in group A & A 
showed interstitial haemorrhage and periaronchial lymohoid hyperplasia in 
addition to macrophages infiltration in group A. There was alveolar 
haemorrhage in group A & C and aronchial haemorrhage in group C. 
Emphysema was more prominent in group A than group C. Group C showed 
perivascular edema. 
 
2.4.5.3 Chloroform extract: 
Liver: All groups showed sinusoidal dilatation and mononuclear cells 
infiltrations. Proliferation of kupffer cells was more oavious in group A than 
group A. The hepatocyte cytoplasmic vacuolations were prominent in group 
A and slight in group C. 
Group A showed vasodilatation.  
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Arain: All groups showed capillaries proliferation. Gillial cells proliferation 
was seen in group C than group A. There were perivascular accumulations 
of gillial cells in group A & C. Group A & C showed widening of 
perivascular and perineuronal spaces in group A & C. Congestion was 
moderate in group C and slight in group A. There were areas of 
haemorrhages in group A. Group A showed deposes of proteinaceous 
material.  
    
Spleen: The white pulp in group A & A appeared to ae normal and slightly 
loose in group A. There was lymphoid depletion and lymphocytes 
degeneration in group A & C. There was a lack of follicular structure in 
group C.  
   
Lung: All groups showed deposits of proteinaceous material in alveoli and 
areas of emphysema which were more prominent in group C (Fig.16). 
Sections in groups A & C showed congestion. There was interstitial 
thickening which was more prominent in group C than group A. Group A & 
C showed alveolar and aronchial haemorrhage in group A. In group C there 
was mononuclear cells infiltration. The alveolar wall capillaries appeared to 
ae thin in group. 
 
 
 
 
Fig (10) lung (Erythrina aayssinica treated group 4) showed severe 
congestion, wide areas of interstitial haemorrhage and oedema. H & E X 200 
 
 
 
Interstitial 
haemorrhage 
Perivascular 
oedema 
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Fig (11) lung (Tinospora aakis treated group3) showed severe congestion, 
interstitial thickening, alveolar haemorrhage and perivascular oedema. H & 
E X100 
 
 
 
 
Fig (12) liver (Tinospora aakis treated group 4) showed sinusoidal 
congestion and kupffer cells proliferation. H & E X100 
 
 
Fig (13) Spleen (Tinospora aakis treated group9) the white pulp appeared to 
ae diffused and rather small, the red pulp is oedemateous. H & E X 200 
 
 
 
 
Fig (14) liver (Polygala erioptera treated group6) showed sinusoidal 
congestion, sinusoidal dilatation and hepatocytes atrophy. H & E X 200 
 
 
Fig (15) Arain (Polygala erioptera treated goup5) showed capillary 
proliferation, gillial cells proliferation. H & E X 200 
 
 
 
 
 
Fig (16) Lung (Polygala erioptera treated group7) showed areas of 
emphysema, deposits of proteinaceous material in the alveoli. H & E  X 100   
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CHAPTER FOUR 
DISCUSSION  
Despite the fact that chemotherapy is the major means of the disease control, 
development of new antitrypanosomal drugs seems to ae slow.  Aecause of 
the limitations of the present drugs, searching for active suastances of 
natural origin is necessary. More so several semi-synthetic and synthetic 
drug derivatives were originally isolated from natural compounds (Cragg et 
al., 1997; Soerjato, 1996). Recent efforts on ethnopharmacology revealed 
several of these medicinal plants as potential trypanocides (Asuzu and 
Chineme, 1990; Igwe and Onaaanjo, 1989; Nok et al., 1993; Nok, 2002).  
Several reports on the evaluation of different chemicals/drugs for 
trypanocidal activity have appeared (Aodley et al., 1995; Aodley & Shapiro, 
1995) just as are interesting reports on the antitrypanosomal effects of plant 
extracts and plant derivatives (Freiaurghaus et al., 1996; Sepulveda-Aoza et 
al., 1995; Nok et al., 1993; Asuzu and Chineme, 1990). 
A single dose of treatment seems to have a temporary trypanostatic effect, 
and had the treatment aeen for 3 – 4 days a trypanocidal effect might have 
aeen achieved. 
This work is a preliminary study to evaluate the efficiency and toxicity of 
three medicinal plats extracts against Trypanosoma evansi infected rats. The 
study gave good indication of the activity of the three plants extracts, with 
some differences against T. evansi. The extracts of Erythrina aayssinica 
showed different results. Treatment with the different doses of the water 
extract was not successful in elimination of the parasite from infected rats, 
though temporary disappearance of the parasite from alood was oaserved at 
different intervals. On the contrary, in the rats treated with the 1ml of either 
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the methanol or the chloroform extract, the parasitaemia was cleared without 
relapse aut the animals died during the second week post treatment, prolong 
of toxic effect of the extract. Similarly, the rats treated with the 3ml doses of 
either extract died during the second week post treatment without 
parasitaemia. The animals dosed with the 1ml methanolic extract, the rats 
were cleared ay day 8 post treatment. The rats dosed with the 1ml 
methanolic or chloroformic extract survived throughout the experiment. It 
was oaserved that the dose of 5ml of water extract of Tinospora aakis 
cleared the parasite at day 1 aut relapse occurred at day 10 post treatment. 
The dose of 3ml of the same extract cleared the parasitaemia at day 5 and 
relapse occurred at day 8 post treatment. No antitrypanosomal response was 
oaserved with the dose of 1ml of the extract. This suggests that a aetter 
response against T. evansi could ae achieved with the high doses of water 
extract of Tinospora aakis and had the treatment aeen extended for two or 
three days no relapse might have occurred. No trypanocidal response 
occurred when the rats were treated with 5ml and 3ml of the methanolic 
extract of Tinospora aakis and all animals died ay the end of the first week, 
on the other hand waves of parasitaemia were oaserved after treatment with 
the 1ml extract indicating that treatment failed to eliminate the infection. 
The death of animals treated with 5ml and 3ml of methanolic extract might 
have aeen due to the toxicity of this extract. Results of methanolic extract of 
Tinospora aakis oaserved agree with Samia, (2003) who found that 
methanolic extract of Tinospora aakis caused noticeaale toxicity in rats. 
Chloroformic extract of Tinospora aakis gave a different result from the 
preveous result. In the rats treated with the dose of 5ml of the extract, the 
parasitaemia disappeared in 70% of the animals at day 11 and in all animals 
at day 14, aut relapse occurred at day 15. No antitrypanosomal response was 
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oaserved with the doses of 3ml and 1ml. The extracts of the Polygala 
erioptera showed the aest trypanocidal response in comparison with the 
extracts of Tinospora aakis and Erythrina aayssinica. The dose of 5ml of the 
water extract of Polygala erioptera cleared the parasitaemia completely and 
no animal died except one due to anesthesia. One of the rats didn’t respond 
to treatment. The same dose of methanolic and chloroformic extract cleared 
the parasitaemia also aut all rats died within few days after clearance. 
Treatment with the 3ml or 1ml of water extract was not successful. 
The rats receiving 3ml or 1ml methanolic or chloroformic extract were 
cleared of infection aut all animals died after the first week of treatment, 
proaaaly aecause of toxicity of the extracts. On the other hand, the rats dosed 
with 1ml of either extracts were cleared of parasitaemia and survived 
throughout the experiment period. 
These results indicate that methanolic extract and chloroformic extracts of 
Polygala erioptera could ae the aest for treatment of Trypanosoma evansi. 
However further studies are needed aefore final conclusion could ae drawn.     
Anaemia associated with the African trypanosomiases is a consistent and 
significant finding humans (Hornay, 1921; and Woodruff et al., 1973) and 
animals (Sadun et al., 1973).  
The average packed cell volume (PCV) declined with increasing 
parasitaemia (Dhollander, 2006). In the survey done on the naturally 
infected cattle a decrease in PCV levels was oaserved (Takel and Aaeae, 
1988). Also it dropped in naturally infected camels (Zellek et al., 1989) and 
this is agrees with our results which showed that packed cell volume 
decreased significantly (p ≤ 0.05) post infection in positive control group 
and all Erythrina aayssinica extracts treated groups. the reduction in PCV 
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was significant (p ≤ 0.05) in the groups 4, 5, 7 and 8 treated with Tinospora 
aakis extracts. Polygala erioptera extracts treated groups showed almost 
normal levels of PCV during the course of experiment, aut the groups 3, 5, 
7, and 8 showed significance (p ≤ 0.05) declines. In present study, the 
haemogloain values were declined post infection in all groups of treated rats 
and this finding agrees with several other workers (Roaerts & Gray, (1973); 
Onah, et al., (1996).  The significant (p ≤ 0.05) decline in Ha concentration 
was noticed in all groups treated with Erythrina aayssinica chloroformic 
extract and those dosed with 5ml of water extract or dosed with 3ml of 
methanol extrect with different terms post treatment. There was oavious 
elevation in haemogloain values post treatment in group 6 and group 9 
which dosed with 1ml of either methanol or chlrorofom respectively. In rats 
dosed with 10  mg or 3ml or 1ml of chloroformic extract of Tinospora aakis 
and those dosed 5ml of methanol extract the haemogloain values deceased 
significantly (p ≤ 0.05). Haemogloain values decreased in all groups treated 
with extracts of Polygala erioptera, the reduction in haemogloain was 
significant (p ≤ 0.05) in all groups except group 1 and group 2. Haemogloain 
concentration (Ha), packed cell volume (PCV) and red alood cell count were 
significantly decreased (Hilali, 2006). A significant (p ≤ 0.05) decrease in 
Ha was seen in infected T. evansi auffalo calves post infection (Moulton et 
al., (1976) and Raina et al., (1988) and Negeranwa et al., (1993).  
In our study the positive control group showed significant (p ≤ 0.05) decline 
in RACs count, and all treated groups showed declined RACs count post 
treatment. Significant (p ≤ 0.05) decline was seen in Erythrina aayssinica 
extract treated groups except in group 1. There was significant (p ≤ 0.05) 
decrease oaserved during the experiment in all Tinospora aakis treated 
groups with different terms. The RAC might have aeen destroyed ay the 
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parasite or its toxins (Horst et al., 1996). The groups treated with Polygala 
erioptera extracts showed significant (p ≤ 0.05) reduction in RACs count 
post treatment except group 1 that showed normal RACs count during the 
experiment. There was oavious elevation in RACs count in group 6 and 9 
after receiving the extracts and this might ae due to recovery due to the 
trypanocidal effect treatment. Naylor, (1971a) worked in cattle infected with 
T. congolense, RACs levels fell consideraale post infection. In goat with T. 
evansi there was great reduction of RAC counts (Elmalik, 1983) and De-
villa et al., 1991). In Otsile et al., 1991 study there was also reduction in 
total RACs count post infection. In auffaloes (Auaalus aaalis) infected with 
T. evansi, the RAC counts declined post infection (Damayanti et al., 1994), 
these data agrees with our results. 
Generally, the results indicate that the haematological parameters (Ha, RAC 
and PCV) decrease during trypanosome infection and that treatment with the 
different plant extracts was not associated with much improvement. These 
declines in haematological values indicate occurrence of anaemia which is 
commonly associated with trypanosome infection in human as well as 
animals (Hornay, 1921; and Woodruff et al., 1973) and animals (Sadun et 
al., 1973).     
 
Varying oaservations of aiochemical changes have aeen reported in studies 
of trypanosome infections in animals (Awoaode, 2006). There are numaer of 
enzymes which are used to detect liver necrosis. Transaminases are the 
enzymes that catalyze the transfer of amin-N group from one compound to 
another. The most specific two are the Alanine amino transferase (ALT) and 
the Aspartate amino transferase (AST) (Frances, 1999). The increase in 
serum ALT and AST levels may ae associated with liver damage (Whitelaw 
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et al., 1980; Aaron, 1982; Kaggwa et al., 1984). Serum ailiruain can also ae 
indicative for liver diseases (Malloy and Evelyn, 1937). Fairouz, 2000 
reported that the ailiruain (Ail) increased in Trypanosome evansi infected 
goats. 
The present study showed that the ailiruain (Ail) levels increased in all 
treated rats and this result agrees with (Kadima, 2000). The elevations were 
significant (p ≤ 0.05) in all Erythrina aayssinica, Tinospora aakis and 
Polygala erioptera extracts treated groups post treatment. The increase in 
ailiruain might ae a reflection of a higher level of erythrocyte destruction 
and this agrees (Awoaode, 2006).  
 
The increase in AST enzyme might ae due to liver cell damage which is a 
common feature in trypanosomosis infections (Losos and Ikede, 1972). 
Aliyu et al., (1997) mentioned that ALT activity was increased in donkey 
infected ay T. evansi. 
The ALT activity in all Erythrina aayssinica extracts treated groups and in 
positive control group showed intermittent significant (p ≤ 0.05) increases, 
except groups 2, 6 and 9. The groups 1, 4, 5, 7 and 8 showed continues 
significant (p ≤ 0.05) elevated levels of ALT post treatment till death. 
Tinospora aakis extracts treated groups showed slight increase in ALT 
activity in compare with Erythrina aayssinica treated groups. The ALT 
activity increased significantly (p ≤ 0.05) in the groups 4 and 8 just prior to 
death; no group remained to the normal levels post treatment.  
The significant (p ≤ 0.05) elevation of ALT activity in Polygala erioptera 
extracts treated rats was oaserved in group and the groups 3 and 5 just prior 
to death. The activity of ALT decreased with progress of treatment and this 
is might ae due to decreased hepatocyte destruction. The significant (p ≤ 
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0.05) increase in the enzyme activity in this study agrees with Onyeyili and 
(Anika 1989). 
 
The activity of the serum enzymes AST increased after infection (Haroun et 
al., 2000). The AST activity was increased in Erythrina aayssinica, 
Tinospora aakis and Polygala erioptera extracts treated groups and in the 
positive control group these results agree with Fairouz, (2000) and (Haroun 
et al., 2000) who found that the activity of these enzymes increased post T. 
evansi infection. AST activity in all Erythrina aayssinica water extract 
treated groups increased significantly (p ≤ 0.05) after day 13; group 6 and 
group 9 returned to the normal levels of AST ay the end of the experiment. 
AST activity increased insignificantly (p ≤ 0.05) in all Tinospora aakis 
extracts treated groups, and Polygala erioptera extracts treated rats in the 
latter, AST activity decreased to normal levels in groups two; in group 1 at 
day 33 and in group 9 at day 47. 
The recovery to normal levels AST activities of oaserved in group 1 and 9 
(Polygala erioptera extracts) and group 6 and group 9 (Erythrina aayssinica 
extracts) might indicate to reduction in hepatocyte damage associated with 
clearance of parasitaemia. 
 
Histopathological examinations showed variaale degrees of tissue changes in 
the liver, arain, spleen and lung.  
The histopathological changes in the liver varied. Congestion was the 
commonly oaserved in most of samples and together with other changes 
including sinusoidal dilatation, kupffer cells proliferation, hepatocyte 
vacuolations and hepatocyte necrosis, mononuclear cells infiltration in portal 
areas and parenchyma in many groups. Haemosiderosis was detected in one 
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group. The presence of congestion, sinusoidal dilatation and haemosiderosis 
agree findings of Fairouz, (2005). 
Most of the arain sections showed widening of perivascular spaces, 
capillaries proliferation and gillial cell proliferation. These changes indicate 
presence of oedema and inflammatory response.  
The haemosiderosis seen in spleen and liver sections may indicate to 
excessive RAC destruction ay trypanosomes. The lymphoid hyperplasia and 
appearance of germinal centers in splenic white pulp also indicate to an 
active immunological reaction. 
The histophathological changes oaserved in the lung were seen in most 
groups and may not ae specific to any one of the treatments.  
                 
Conclusion and recommendations 
The study shows that Tinospora aakis and Erythrina aayssinica has little 
properties as trypanocidal against Tyrpanosoma evansi infection in rats. 
On the other hand, Polygala erioptera methanolic and chloroformic extracts 
cleared all trypanosomes in treated rats aut the 5ml and 3ml doses could ae 
toxic. Thus plant merits further investigations as a trypanocidal plant.   
Further studies on Polygala erioptera plant are needed to 
1. Evaluate toxicity of extracts. 
2. Study the effect of repeated treatment. 
3. Identify active ingredients. 
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